{"id":102412,"date":"2025-05-27T03:06:18","date_gmt":"2025-05-27T03:06:18","guid":{"rendered":"https:\/\/www.dumpsbase.com\/freedumps\/?p=102412"},"modified":"2025-05-27T03:06:18","modified_gmt":"2025-05-27T03:06:18","slug":"get-acrp-cp-dumps-v8-02-to-practice-the-latest-acrp-cp-test-questions-pass-your-acrp-certified-professional-exam-smoothly","status":"publish","type":"post","link":"https:\/\/www.dumpsbase.com\/freedumps\/get-acrp-cp-dumps-v8-02-to-practice-the-latest-acrp-cp-test-questions-pass-your-acrp-certified-professional-exam-smoothly.html","title":{"rendered":"Get ACRP-CP Dumps (V8.02) to Practice the Latest ACRP-CP Test Questions: Pass Your ACRP Certified Professional Exam Smoothly"},"content":{"rendered":"<p>When visiting the <a href=\"https:\/\/www.dumpsbase.com\/acrp-cp.html\"><em><strong>ACRP-CP dumps of DumpsBase<\/strong><\/em><\/a>, you may know, \u201cDumpsBase offers the latest ACRP-CP exam dumps, expertly crafted to match the actual exam format and content. These practice questions will help you optimize your study time, build confidence, and increase your chances of passing the ACRP-Certified Professional (ACRP-CP) exam on your first attempt.\u201d If you decide to take the ACRP-CP exam by learning the ACRP-CP dumps (V8.02), you can practice all the latest test questions to make preparations. With DumpsBase ACRP-CP exam dumps, you can do exactly that! Our expertly crafted ACRP-CP test questions are designed to help you prepare thoroughly, ensuring you understand every concept and are well-equipped for any question that might come your way. Get ACRP-CP dumps (V8.02) to practice your questions and answers. With our comprehensive exam dumps, you&#8217;ll be well on your way to passing the ACRP Certified Professional Exam smoothly.<\/p>\n<h2>Below are the <em><span style=\"background-color: #00ffff;\">ACRP-CP free dumps<\/span><\/em> to help you check the quality:<\/h2>\n<script>\n\t  window.fbAsyncInit = function() {\n\t    FB.init({\n\t      appId            : '622169541470367',\n\t      autoLogAppEvents : true,\n\t      xfbml            : true,\n\t      version          : 'v3.1'\n\t    });\n\t  };\n\t\n\t  (function(d, s, id){\n\t     var js, fjs = d.getElementsByTagName(s)[0];\n\t     if (d.getElementById(id)) {return;}\n\t     js = d.createElement(s); js.id = id;\n\t     js.src = \"https:\/\/connect.facebook.net\/en_US\/sdk.js\";\n\t     fjs.parentNode.insertBefore(js, fjs);\n\t   }(document, 'script', 'facebook-jssdk'));\n\t<\/script><script type=\"text\/javascript\" >\ndocument.addEventListener(\"DOMContentLoaded\", function(event) { \nif(!window.jQuery) alert(\"The important jQuery library is not properly loaded in your site. Your WordPress theme is probably missing the essential wp_head() call. You can switch to another theme and you will see that the plugin works fine and this notice disappears. If you are still not sure what to do you can contact us for help.\");\n});\n<\/script>  \n  \n<div  id=\"watupro_quiz\" class=\"quiz-area single-page-quiz\">\n<p id=\"submittingExam10077\" style=\"display:none;text-align:center;\"><img loading=\"lazy\" decoding=\"async\" src=\"https:\/\/www.dumpsbase.com\/freedumps\/wp-content\/plugins\/watupro\/img\/loading.gif\" width=\"16\" height=\"16\"><\/p>\n\n<div class=\"watupro-exam-description\" id=\"description-quiz-10077\"><\/div>\n\n<form action=\"\" method=\"post\" class=\"quiz-form\" id=\"quiz-10077\"  enctype=\"multipart\/form-data\" >\n<div class='watu-question ' id='question-1' style=';'><div id='questionWrap-1'  class='   watupro-question-id-400367'>\n\t\t\t<div class='question-content'><div><span class='watupro_num'>1. <\/span>An investigator in a multicenter trial reports multiple occurrences of an SAE to the sponsor. <br \/>\r<br>Who is responsible for reporting the SAEs to the remaining sites' IRB\/IECs?<\/div><input type='hidden' name='question_id[]' id='qID_1' value='400367' \/><input type='hidden' id='answerType400367' value='radio'><!-- end question-content--><\/div><div class='question-choices watupro-choices-columns '><div class='watupro-question-choice  ' dir='auto' ><input type='radio' name='answer-400367[]' id='answer-id-1554891' class='answer   answerof-400367 ' value='1554891'   \/><label for='answer-id-1554891' id='answer-label-1554891' class=' answer'><span>Study sponsor<\/span><\/label><\/div><div class='watupro-question-choice  ' dir='auto' ><input type='radio' name='answer-400367[]' id='answer-id-1554892' class='answer   answerof-400367 ' value='1554892'   \/><label for='answer-id-1554892' id='answer-label-1554892' class=' answer'><span>Regulatory authority<\/span><\/label><\/div><div class='watupro-question-choice  ' dir='auto' ><input type='radio' name='answer-400367[]' id='answer-id-1554893' class='answer   answerof-400367 ' value='1554893'   \/><label for='answer-id-1554893' id='answer-label-1554893' class=' answer'><span>Investigator at each site<\/span><\/label><\/div><div class='watupro-question-choice  ' dir='auto' ><input type='radio' name='answer-400367[]' id='answer-id-1554894' class='answer   answerof-400367 ' value='1554894'   \/><label for='answer-id-1554894' id='answer-label-1554894' class=' answer'><span>Original reporting investigator<\/span><\/label><\/div><!-- end question-choices--><\/div><!-- end questionWrap--><\/div><\/div><div class='watu-question ' id='question-2' style=';'><div id='questionWrap-2'  class='   watupro-question-id-400368'>\n\t\t\t<div class='question-content'><div><span class='watupro_num'>2. <\/span>A clinical trial is conducted to test the effect of an investigational drug on cholesterol levels. <br \/>\r<br>Statistical analysis will be performed to:<\/div><input type='hidden' name='question_id[]' id='qID_2' value='400368' \/><input type='hidden' id='answerType400368' value='radio'><!-- end question-content--><\/div><div class='question-choices watupro-choices-columns '><div class='watupro-question-choice  ' dir='auto' ><input type='radio' name='answer-400368[]' id='answer-id-1554895' class='answer   answerof-400368 ' value='1554895'   \/><label for='answer-id-1554895' id='answer-label-1554895' class=' answer'><span>Reject the alternative hypothesis that the drug has no effect on cholesterol levels.<\/span><\/label><\/div><div class='watupro-question-choice  ' dir='auto' ><input type='radio' name='answer-400368[]' id='answer-id-1554896' class='answer   answerof-400368 ' value='1554896'   \/><label for='answer-id-1554896' id='answer-label-1554896' class=' answer'><span>Reject the null hypothesis that the drug has no effect on cholesterol levels.<\/span><\/label><\/div><div class='watupro-question-choice  ' dir='auto' ><input type='radio' name='answer-400368[]' id='answer-id-1554897' class='answer   answerof-400368 ' value='1554897'   \/><label for='answer-id-1554897' id='answer-label-1554897' class=' answer'><span>Fail to reject the null hypothesis that the drug has an effect on cholesterol levels.<\/span><\/label><\/div><div class='watupro-question-choice  ' dir='auto' ><input type='radio' name='answer-400368[]' id='answer-id-1554898' class='answer   answerof-400368 ' value='1554898'   \/><label for='answer-id-1554898' id='answer-label-1554898' class=' answer'><span>Fail to reject the alternative hypothesis that the drug has an effect on cholesterol levels.<\/span><\/label><\/div><!-- end question-choices--><\/div><!-- end questionWrap--><\/div><\/div><div class='watu-question ' id='question-3' style=';'><div id='questionWrap-3'  class='   watupro-question-id-400369'>\n\t\t\t<div class='question-content'><div><span class='watupro_num'>3. <\/span>While reviewing reports of data completion, the sponsor notices low retention rates at many participating sites. <br \/>\r<br>What is an appropriate FIRST action for the sponsor to take?<\/div><input type='hidden' name='question_id[]' id='qID_3' value='400369' \/><input type='hidden' id='answerType400369' value='radio'><!-- end question-content--><\/div><div class='question-choices watupro-choices-columns '><div class='watupro-question-choice  ' dir='auto' ><input type='radio' name='answer-400369[]' id='answer-id-1554899' class='answer   answerof-400369 ' value='1554899'   \/><label for='answer-id-1554899' id='answer-label-1554899' class=' answer'><span>Interview participants who have dropped out.<\/span><\/label><\/div><div class='watupro-question-choice  ' dir='auto' ><input type='radio' name='answer-400369[]' id='answer-id-1554900' class='answer   answerof-400369 ' value='1554900'   \/><label for='answer-id-1554900' id='answer-label-1554900' class=' answer'><span>Require participants to provide documented reason for withdrawal.<\/span><\/label><\/div><div class='watupro-question-choice  ' dir='auto' ><input type='radio' name='answer-400369[]' id='answer-id-1554901' class='answer   answerof-400369 ' value='1554901'   \/><label for='answer-id-1554901' id='answer-label-1554901' class=' answer'><span>Submit revised ICFs to the IRB\/IEC with increased compensation for participants.<\/span><\/label><\/div><div class='watupro-question-choice  ' dir='auto' ><input type='radio' name='answer-400369[]' id='answer-id-1554902' class='answer   answerof-400369 ' value='1554902'   \/><label for='answer-id-1554902' id='answer-label-1554902' class=' answer'><span>Meet with the site staff to understand their workflows and to review retention strategies.<\/span><\/label><\/div><!-- end question-choices--><\/div><!-- end questionWrap--><\/div><\/div><div class='watu-question ' id='question-4' style=';'><div id='questionWrap-4'  class='   watupro-question-id-400370'>\n\t\t\t<div class='question-content'><div><span class='watupro_num'>4. <\/span>The PI should ensure that source data is:<\/div><input type='hidden' name='question_id[]' id='qID_4' value='400370' \/><input type='hidden' id='answerType400370' value='radio'><!-- end question-content--><\/div><div class='question-choices watupro-choices-columns '><div class='watupro-question-choice  ' dir='auto' ><input type='radio' name='answer-400370[]' id='answer-id-1554903' class='answer   answerof-400370 ' value='1554903'   \/><label for='answer-id-1554903' id='answer-label-1554903' class=' answer'><span>Kept on site for a minimum of 2 years.<\/span><\/label><\/div><div class='watupro-question-choice  ' dir='auto' ><input type='radio' name='answer-400370[]' id='answer-id-1554904' class='answer   answerof-400370 ' value='1554904'   \/><label for='answer-id-1554904' id='answer-label-1554904' class=' answer'><span>Accurately reflected in the eCRFs.<\/span><\/label><\/div><div class='watupro-question-choice  ' dir='auto' ><input type='radio' name='answer-400370[]' id='answer-id-1554905' class='answer   answerof-400370 ' value='1554905'   \/><label for='answer-id-1554905' id='answer-label-1554905' class=' answer'><span>Printed directly from the EM<\/span><\/label><\/div><div class='watupro-question-choice  ' dir='auto' ><input type='radio' name='answer-400370[]' id='answer-id-1554906' class='answer   answerof-400370 ' value='1554906'   \/><label for='answer-id-1554906' id='answer-label-1554906' class=' answer'><span>On worksheets that are provided by the sponsor.<\/span><\/label><\/div><!-- end question-choices--><\/div><!-- end questionWrap--><\/div><\/div><div class='watu-question ' id='question-5' style=';'><div id='questionWrap-5'  class='   watupro-question-id-400371'>\n\t\t\t<div class='question-content'><div><span class='watupro_num'>5. <\/span>A clinical trial is conducted to measure the effectiveness of music therapy to reduce anxiety in intensive care unit patients. Patients are randomly assigned to receive headphones with music of their choice or headphones with white noise. <br \/>\r<br>The group receiving the white noise headphones is considered which type of control group?<\/div><input type='hidden' name='question_id[]' id='qID_5' value='400371' \/><input type='hidden' id='answerType400371' value='radio'><!-- end question-content--><\/div><div class='question-choices watupro-choices-columns '><div class='watupro-question-choice  ' dir='auto' ><input type='radio' name='answer-400371[]' id='answer-id-1554907' class='answer   answerof-400371 ' value='1554907'   \/><label for='answer-id-1554907' id='answer-label-1554907' class=' answer'><span>Placebo<\/span><\/label><\/div><div class='watupro-question-choice  ' dir='auto' ><input type='radio' name='answer-400371[]' id='answer-id-1554908' class='answer   answerof-400371 ' value='1554908'   \/><label for='answer-id-1554908' id='answer-label-1554908' class=' answer'><span>No treatment<\/span><\/label><\/div><div class='watupro-question-choice  ' dir='auto' ><input type='radio' name='answer-400371[]' id='answer-id-1554909' class='answer   answerof-400371 ' value='1554909'   \/><label for='answer-id-1554909' id='answer-label-1554909' class=' answer'><span>Active control<\/span><\/label><\/div><div class='watupro-question-choice  ' dir='auto' ><input type='radio' name='answer-400371[]' id='answer-id-1554910' class='answer   answerof-400371 ' value='1554910'   \/><label for='answer-id-1554910' id='answer-label-1554910' class=' answer'><span>Alternate dose<\/span><\/label><\/div><!-- end question-choices--><\/div><!-- end questionWrap--><\/div><\/div><div class='watu-question ' id='question-6' style=';'><div id='questionWrap-6'  class='   watupro-question-id-400372'>\n\t\t\t<div class='question-content'><div><span class='watupro_num'>6. <\/span>A new device trial is being considered. Before committing to participate in the trial, what is the MOST important item the PI needs to evaluate?<\/div><input type='hidden' name='question_id[]' id='qID_6' value='400372' \/><input type='hidden' id='answerType400372' value='radio'><!-- end question-content--><\/div><div class='question-choices watupro-choices-columns '><div class='watupro-question-choice  ' dir='auto' ><input type='radio' name='answer-400372[]' id='answer-id-1554911' class='answer   answerof-400372 ' value='1554911'   \/><label for='answer-id-1554911' id='answer-label-1554911' class=' answer'><span>Location of stored trial records<\/span><\/label><\/div><div class='watupro-question-choice  ' dir='auto' ><input type='radio' name='answer-400372[]' id='answer-id-1554912' class='answer   answerof-400372 ' value='1554912'   \/><label for='answer-id-1554912' id='answer-label-1554912' class=' answer'><span>Availability of qualified staff to conduct the trial<\/span><\/label><\/div><div class='watupro-question-choice  ' dir='auto' ><input type='radio' name='answer-400372[]' id='answer-id-1554913' class='answer   answerof-400372 ' value='1554913'   \/><label for='answer-id-1554913' id='answer-label-1554913' class=' answer'><span>Information to be included in the advertising flyer<\/span><\/label><\/div><div class='watupro-question-choice  ' dir='auto' ><input type='radio' name='answer-400372[]' id='answer-id-1554914' class='answer   answerof-400372 ' value='1554914'   \/><label for='answer-id-1554914' id='answer-label-1554914' class=' answer'><span>Length of time to receive the approved trial device<\/span><\/label><\/div><!-- end question-choices--><\/div><!-- end questionWrap--><\/div><\/div><div class='watu-question ' id='question-7' style=';'><div id='questionWrap-7'  class='   watupro-question-id-400373'>\n\t\t\t<div class='question-content'><div><span class='watupro_num'>7. <\/span>Who is responsible for defining, establishing, and allocating all trial-related duties and functions prior to initiating a trial?<\/div><input type='hidden' name='question_id[]' id='qID_7' value='400373' \/><input type='hidden' id='answerType400373' value='radio'><!-- end question-content--><\/div><div class='question-choices watupro-choices-columns '><div class='watupro-question-choice  ' dir='auto' ><input type='radio' name='answer-400373[]' id='answer-id-1554915' class='answer   answerof-400373 ' value='1554915'   \/><label for='answer-id-1554915' id='answer-label-1554915' class=' answer'><span>Investigator<\/span><\/label><\/div><div class='watupro-question-choice  ' dir='auto' ><input type='radio' name='answer-400373[]' id='answer-id-1554916' class='answer   answerof-400373 ' value='1554916'   \/><label for='answer-id-1554916' id='answer-label-1554916' class=' answer'><span>CRO<\/span><\/label><\/div><div class='watupro-question-choice  ' dir='auto' ><input type='radio' name='answer-400373[]' id='answer-id-1554917' class='answer   answerof-400373 ' value='1554917'   \/><label for='answer-id-1554917' id='answer-label-1554917' class=' answer'><span>Sponsor<\/span><\/label><\/div><div class='watupro-question-choice  ' dir='auto' ><input type='radio' name='answer-400373[]' id='answer-id-1554918' class='answer   answerof-400373 ' value='1554918'   \/><label for='answer-id-1554918' id='answer-label-1554918' class=' answer'><span>IRB\/IEC<\/span><\/label><\/div><!-- end question-choices--><\/div><!-- end questionWrap--><\/div><\/div><div class='watu-question ' id='question-8' style=';'><div id='questionWrap-8'  class='   watupro-question-id-400374'>\n\t\t\t<div class='question-content'><div><span class='watupro_num'>8. <\/span>Who determines what criteria and procedures should be followed if a subject discontinues\/withdraws their consent?<\/div><input type='hidden' name='question_id[]' id='qID_8' value='400374' \/><input type='hidden' id='answerType400374' value='radio'><!-- end question-content--><\/div><div class='question-choices watupro-choices-columns '><div class='watupro-question-choice  ' dir='auto' ><input type='radio' name='answer-400374[]' id='answer-id-1554919' class='answer   answerof-400374 ' value='1554919'   \/><label for='answer-id-1554919' id='answer-label-1554919' class=' answer'><span>CRO<\/span><\/label><\/div><div class='watupro-question-choice  ' dir='auto' ><input type='radio' name='answer-400374[]' id='answer-id-1554920' class='answer   answerof-400374 ' value='1554920'   \/><label for='answer-id-1554920' id='answer-label-1554920' class=' answer'><span>Subject<\/span><\/label><\/div><div class='watupro-question-choice  ' dir='auto' ><input type='radio' name='answer-400374[]' id='answer-id-1554921' class='answer   answerof-400374 ' value='1554921'   \/><label for='answer-id-1554921' id='answer-label-1554921' class=' answer'><span>PI<\/span><\/label><\/div><div class='watupro-question-choice  ' dir='auto' ><input type='radio' name='answer-400374[]' id='answer-id-1554922' class='answer   answerof-400374 ' value='1554922'   \/><label for='answer-id-1554922' id='answer-label-1554922' class=' answer'><span>Sponsor<\/span><\/label><\/div><!-- end question-choices--><\/div><!-- end questionWrap--><\/div><\/div><div class='watu-question ' id='question-9' style=';'><div id='questionWrap-9'  class='   watupro-question-id-400375'>\n\t\t\t<div class='question-content'><div><span class='watupro_num'>9. <\/span>A study has been closed for two years after the last approval of a marketing application of an IP. No additional applications are pending and there are no further developments planned for the IP. <br \/>\r<br>Which of the following statements is the BEST course of action regarding the destruction of the essential documents?<\/div><input type='hidden' name='question_id[]' id='qID_9' value='400375' \/><input type='hidden' id='answerType400375' value='radio'><!-- end question-content--><\/div><div class='question-choices watupro-choices-columns '><div class='watupro-question-choice  ' dir='auto' ><input type='radio' name='answer-400375[]' id='answer-id-1554923' class='answer   answerof-400375 ' value='1554923'   \/><label for='answer-id-1554923' id='answer-label-1554923' class=' answer'><span>The site may proceed with the destruction of the essential documents.<\/span><\/label><\/div><div class='watupro-question-choice  ' dir='auto' ><input type='radio' name='answer-400375[]' id='answer-id-1554924' class='answer   answerof-400375 ' value='1554924'   \/><label for='answer-id-1554924' id='answer-label-1554924' class=' answer'><span>The site should retain the essential documents longer to meet the regulatory requirements.<\/span><\/label><\/div><div class='watupro-question-choice  ' dir='auto' ><input type='radio' name='answer-400375[]' id='answer-id-1554925' class='answer   answerof-400375 ' value='1554925'   \/><label for='answer-id-1554925' id='answer-label-1554925' class=' answer'><span>The site should contact the sponsor and receive written notification prior to destruction that the essential documents are no longer needed.<\/span><\/label><\/div><div class='watupro-question-choice  ' dir='auto' ><input type='radio' name='answer-400375[]' id='answer-id-1554926' class='answer   answerof-400375 ' value='1554926'   \/><label for='answer-id-1554926' id='answer-label-1554926' class=' answer'><span>The site should contact the sponsor and receive verbal notification they are no longer needed and the essential documents may be destroyed.<\/span><\/label><\/div><!-- end question-choices--><\/div><!-- end questionWrap--><\/div><\/div><div class='watu-question ' id='question-10' style=';'><div id='questionWrap-10'  class='   watupro-question-id-400376'>\n\t\t\t<div class='question-content'><div><span class='watupro_num'>10. <\/span>The IRB\/IEC has decided to not approve a clinical trial. <br \/>\r<br>Who must they notify in writing?<\/div><input type='hidden' name='question_id[]' id='qID_10' value='400376' \/><input type='hidden' id='answerType400376' value='radio'><!-- end question-content--><\/div><div class='question-choices watupro-choices-columns '><div class='watupro-question-choice  ' dir='auto' ><input type='radio' name='answer-400376[]' id='answer-id-1554927' class='answer   answerof-400376 ' value='1554927'   \/><label for='answer-id-1554927' id='answer-label-1554927' class=' answer'><span>PI<\/span><\/label><\/div><div class='watupro-question-choice  ' dir='auto' ><input type='radio' name='answer-400376[]' id='answer-id-1554928' class='answer   answerof-400376 ' value='1554928'   \/><label for='answer-id-1554928' id='answer-label-1554928' class=' answer'><span>CRC<\/span><\/label><\/div><div class='watupro-question-choice  ' dir='auto' ><input type='radio' name='answer-400376[]' id='answer-id-1554929' class='answer   answerof-400376 ' value='1554929'   \/><label for='answer-id-1554929' id='answer-label-1554929' class=' answer'><span>Sponsor<\/span><\/label><\/div><div class='watupro-question-choice  ' dir='auto' ><input type='radio' name='answer-400376[]' id='answer-id-1554930' class='answer   answerof-400376 ' value='1554930'   \/><label for='answer-id-1554930' id='answer-label-1554930' class=' answer'><span>Regulatory Agency<\/span><\/label><\/div><!-- end question-choices--><\/div><!-- end questionWrap--><\/div><\/div><div class='watu-question ' id='question-11' style=';'><div id='questionWrap-11'  class='   watupro-question-id-400377'>\n\t\t\t<div class='question-content'><div><span class='watupro_num'>11. <\/span>A PI is reviewing the CRF for a recent subject visit and notices the participant's heart rate and temperature are not recorded. <br \/>\r<br>Which of the following study documentation practices was neglected?<\/div><input type='hidden' name='question_id[]' id='qID_11' value='400377' \/><input type='hidden' id='answerType400377' value='radio'><!-- end question-content--><\/div><div class='question-choices watupro-choices-columns '><div class='watupro-question-choice  ' dir='auto' ><input type='radio' name='answer-400377[]' id='answer-id-1554931' class='answer   answerof-400377 ' value='1554931'   \/><label for='answer-id-1554931' id='answer-label-1554931' class=' answer'><span>Original<\/span><\/label><\/div><div class='watupro-question-choice  ' dir='auto' ><input type='radio' name='answer-400377[]' id='answer-id-1554932' class='answer   answerof-400377 ' value='1554932'   \/><label for='answer-id-1554932' id='answer-label-1554932' class=' answer'><span>Complete<\/span><\/label><\/div><div class='watupro-question-choice  ' dir='auto' ><input type='radio' name='answer-400377[]' id='answer-id-1554933' class='answer   answerof-400377 ' value='1554933'   \/><label for='answer-id-1554933' id='answer-label-1554933' class=' answer'><span>Attributable<\/span><\/label><\/div><div class='watupro-question-choice  ' dir='auto' ><input type='radio' name='answer-400377[]' id='answer-id-1554934' class='answer   answerof-400377 ' value='1554934'   \/><label for='answer-id-1554934' id='answer-label-1554934' class=' answer'><span>Contemporaneous<\/span><\/label><\/div><!-- end question-choices--><\/div><!-- end questionWrap--><\/div><\/div><div class='watu-question ' id='question-12' style=';'><div id='questionWrap-12'  class='   watupro-question-id-400378'>\n\t\t\t<div class='question-content'><div><span class='watupro_num'>12. <\/span>Which of the following activities is the MOST efficient way of overseeing a CRO\u2019s management during a clinical trial?<\/div><input type='hidden' name='question_id[]' id='qID_12' value='400378' \/><input type='hidden' id='answerType400378' value='radio'><!-- end question-content--><\/div><div class='question-choices watupro-choices-columns '><div class='watupro-question-choice  ' dir='auto' ><input type='radio' name='answer-400378[]' id='answer-id-1554935' class='answer   answerof-400378 ' value='1554935'   \/><label for='answer-id-1554935' id='answer-label-1554935' class=' answer'><span>Pre-qualification assessment of CRO<\/span><\/label><\/div><div class='watupro-question-choice  ' dir='auto' ><input type='radio' name='answer-400378[]' id='answer-id-1554936' class='answer   answerof-400378 ' value='1554936'   \/><label for='answer-id-1554936' id='answer-label-1554936' class=' answer'><span>Co-monitoring of CRO site visits<\/span><\/label><\/div><div class='watupro-question-choice  ' dir='auto' ><input type='radio' name='answer-400378[]' id='answer-id-1554937' class='answer   answerof-400378 ' value='1554937'   \/><label for='answer-id-1554937' id='answer-label-1554937' class=' answer'><span>Central monitoring of data fields by sponsor<\/span><\/label><\/div><div class='watupro-question-choice  ' dir='auto' ><input type='radio' name='answer-400378[]' id='answer-id-1554938' class='answer   answerof-400378 ' value='1554938'   \/><label for='answer-id-1554938' id='answer-label-1554938' class=' answer'><span>Risk-based audits of CRO activities as delegated<\/span><\/label><\/div><!-- end question-choices--><\/div><!-- end questionWrap--><\/div><\/div><div class='watu-question ' id='question-13' style=';'><div id='questionWrap-13'  class='   watupro-question-id-400379'>\n\t\t\t<div class='question-content'><div><span class='watupro_num'>13. <\/span>In an investigator-initiated study, who is responsible for implementing appropriate corrective and preventive actions when significant non-compliance is discovered?<\/div><input type='hidden' name='question_id[]' id='qID_13' value='400379' \/><input type='hidden' id='answerType400379' value='radio'><!-- end question-content--><\/div><div class='question-choices watupro-choices-columns '><div class='watupro-question-choice  ' dir='auto' ><input type='radio' name='answer-400379[]' id='answer-id-1554939' class='answer   answerof-400379 ' value='1554939'   \/><label for='answer-id-1554939' id='answer-label-1554939' class=' answer'><span>PI<\/span><\/label><\/div><div class='watupro-question-choice  ' dir='auto' ><input type='radio' name='answer-400379[]' id='answer-id-1554940' class='answer   answerof-400379 ' value='1554940'   \/><label for='answer-id-1554940' id='answer-label-1554940' class=' answer'><span>IRB\/IEC<\/span><\/label><\/div><div class='watupro-question-choice  ' dir='auto' ><input type='radio' name='answer-400379[]' id='answer-id-1554941' class='answer   answerof-400379 ' value='1554941'   \/><label for='answer-id-1554941' id='answer-label-1554941' class=' answer'><span>CRA<\/span><\/label><\/div><div class='watupro-question-choice  ' dir='auto' ><input type='radio' name='answer-400379[]' id='answer-id-1554942' class='answer   answerof-400379 ' value='1554942'   \/><label for='answer-id-1554942' id='answer-label-1554942' class=' answer'><span>CRC<\/span><\/label><\/div><!-- end question-choices--><\/div><!-- end questionWrap--><\/div><\/div><div class='watu-question ' id='question-14' style=';'><div id='questionWrap-14'  class='   watupro-question-id-400380'>\n\t\t\t<div class='question-content'><div><span class='watupro_num'>14. <\/span>At a close-out visit, which document should be retained only at the site?<\/div><input type='hidden' name='question_id[]' id='qID_14' value='400380' \/><input type='hidden' id='answerType400380' value='radio'><!-- end question-content--><\/div><div class='question-choices watupro-choices-columns '><div class='watupro-question-choice  ' dir='auto' ><input type='radio' name='answer-400380[]' id='answer-id-1554943' class='answer   answerof-400380 ' value='1554943'   \/><label for='answer-id-1554943' id='answer-label-1554943' class=' answer'><span>IP accountability<\/span><\/label><\/div><div class='watupro-question-choice  ' dir='auto' ><input type='radio' name='answer-400380[]' id='answer-id-1554944' class='answer   answerof-400380 ' value='1554944'   \/><label for='answer-id-1554944' id='answer-label-1554944' class=' answer'><span>Treatment allocation<\/span><\/label><\/div><div class='watupro-question-choice  ' dir='auto' ><input type='radio' name='answer-400380[]' id='answer-id-1554945' class='answer   answerof-400380 ' value='1554945'   \/><label for='answer-id-1554945' id='answer-label-1554945' class=' answer'><span>Subject identification code list<\/span><\/label><\/div><div class='watupro-question-choice  ' dir='auto' ><input type='radio' name='answer-400380[]' id='answer-id-1554946' class='answer   answerof-400380 ' value='1554946'   \/><label for='answer-id-1554946' id='answer-label-1554946' class=' answer'><span>Final trial close-out monitoring report<\/span><\/label><\/div><!-- end question-choices--><\/div><!-- end questionWrap--><\/div><\/div><div class='watu-question ' id='question-15' style=';'><div id='questionWrap-15'  class='   watupro-question-id-400381'>\n\t\t\t<div class='question-content'><div><span class='watupro_num'>15. <\/span>Who is responsible for the ongoing safety evaluation of the IP?<\/div><input type='hidden' name='question_id[]' id='qID_15' value='400381' \/><input type='hidden' id='answerType400381' value='radio'><!-- end question-content--><\/div><div class='question-choices watupro-choices-columns '><div class='watupro-question-choice  ' dir='auto' ><input type='radio' name='answer-400381[]' id='answer-id-1554947' class='answer   answerof-400381 ' value='1554947'   \/><label for='answer-id-1554947' id='answer-label-1554947' class=' answer'><span>Regulatory agency<\/span><\/label><\/div><div class='watupro-question-choice  ' dir='auto' ><input type='radio' name='answer-400381[]' id='answer-id-1554948' class='answer   answerof-400381 ' value='1554948'   \/><label for='answer-id-1554948' id='answer-label-1554948' class=' answer'><span>IRB\/IEC<\/span><\/label><\/div><div class='watupro-question-choice  ' dir='auto' ><input type='radio' name='answer-400381[]' id='answer-id-1554949' class='answer   answerof-400381 ' value='1554949'   \/><label for='answer-id-1554949' id='answer-label-1554949' class=' answer'><span>Sponsor<\/span><\/label><\/div><div class='watupro-question-choice  ' dir='auto' ><input type='radio' name='answer-400381[]' id='answer-id-1554950' class='answer   answerof-400381 ' value='1554950'   \/><label for='answer-id-1554950' id='answer-label-1554950' class=' answer'><span>PI<\/span><\/label><\/div><!-- end question-choices--><\/div><!-- end questionWrap--><\/div><\/div><div class='watu-question ' id='question-16' style=';'><div id='questionWrap-16'  class='   watupro-question-id-400382'>\n\t\t\t<div class='question-content'><div><span class='watupro_num'>16. <\/span>Which of the following activities would be undertaken by the sponsor to BEST ensure overall quality of the study data?<\/div><input type='hidden' name='question_id[]' id='qID_16' value='400382' \/><input type='hidden' id='answerType400382' value='radio'><!-- end question-content--><\/div><div class='question-choices watupro-choices-columns '><div class='watupro-question-choice  ' dir='auto' ><input type='radio' name='answer-400382[]' id='answer-id-1554951' class='answer   answerof-400382 ' value='1554951'   \/><label for='answer-id-1554951' id='answer-label-1554951' class=' answer'><span>Ensure there is an accompanying written record that describes the consent process.<\/span><\/label><\/div><div class='watupro-question-choice  ' dir='auto' ><input type='radio' name='answer-400382[]' id='answer-id-1554952' class='answer   answerof-400382 ' value='1554952'   \/><label for='answer-id-1554952' id='answer-label-1554952' class=' answer'><span>Conduct annual reviews of the protocol and accompanying study documents.<\/span><\/label><\/div><div class='watupro-question-choice  ' dir='auto' ><input type='radio' name='answer-400382[]' id='answer-id-1554953' class='answer   answerof-400382 ' value='1554953'   \/><label for='answer-id-1554953' id='answer-label-1554953' class=' answer'><span>Develop a plan that describes the monitoring approach for a clinical study.<\/span><\/label><\/div><div class='watupro-question-choice  ' dir='auto' ><input type='radio' name='answer-400382[]' id='answer-id-1554954' class='answer   answerof-400382 ' value='1554954'   \/><label for='answer-id-1554954' id='answer-label-1554954' class=' answer'><span>Ensure submission of a data management plan to the regulatory authorities.<\/span><\/label><\/div><!-- end question-choices--><\/div><!-- end questionWrap--><\/div><\/div><div class='watu-question ' id='question-17' style=';'><div id='questionWrap-17'  class='   watupro-question-id-400383'>\n\t\t\t<div class='question-content'><div><span class='watupro_num'>17. <\/span>While reviewing a new protocol, a PI realizes a specialized laboratory test is required that the local hospital does not perform. The PI locates a laboratory that performs the specialized test and retains their services. <br \/>\r<br>Responsibility for ensuring the laboratory retained is qualified for this trial-related task lies with the:<\/div><input type='hidden' name='question_id[]' id='qID_17' value='400383' \/><input type='hidden' id='answerType400383' value='radio'><!-- end question-content--><\/div><div class='question-choices watupro-choices-columns '><div class='watupro-question-choice  ' dir='auto' ><input type='radio' name='answer-400383[]' id='answer-id-1554955' class='answer   answerof-400383 ' value='1554955'   \/><label for='answer-id-1554955' id='answer-label-1554955' class=' answer'><span>PI<\/span><\/label><\/div><div class='watupro-question-choice  ' dir='auto' ><input type='radio' name='answer-400383[]' id='answer-id-1554956' class='answer   answerof-400383 ' value='1554956'   \/><label for='answer-id-1554956' id='answer-label-1554956' class=' answer'><span>CRC<\/span><\/label><\/div><div class='watupro-question-choice  ' dir='auto' ><input type='radio' name='answer-400383[]' id='answer-id-1554957' class='answer   answerof-400383 ' value='1554957'   \/><label for='answer-id-1554957' id='answer-label-1554957' class=' answer'><span>CRO<\/span><\/label><\/div><div class='watupro-question-choice  ' dir='auto' ><input type='radio' name='answer-400383[]' id='answer-id-1554958' class='answer   answerof-400383 ' value='1554958'   \/><label for='answer-id-1554958' id='answer-label-1554958' class=' answer'><span>Sponsor<\/span><\/label><\/div><!-- end question-choices--><\/div><!-- end questionWrap--><\/div><\/div><div class='watu-question ' id='question-18' style=';'><div id='questionWrap-18'  class='   watupro-question-id-400384'>\n\t\t\t<div class='question-content'><div><span class='watupro_num'>18. <\/span>All site financial matters pertaining to a trial are listed in what document?<\/div><input type='hidden' name='question_id[]' id='qID_18' value='400384' \/><input type='hidden' id='answerType400384' value='radio'><!-- end question-content--><\/div><div class='question-choices watupro-choices-columns '><div class='watupro-question-choice  ' dir='auto' ><input type='radio' name='answer-400384[]' id='answer-id-1554959' class='answer   answerof-400384 ' value='1554959'   \/><label for='answer-id-1554959' id='answer-label-1554959' class=' answer'><span>Signed contract<\/span><\/label><\/div><div class='watupro-question-choice  ' dir='auto' ><input type='radio' name='answer-400384[]' id='answer-id-1554960' class='answer   answerof-400384 ' value='1554960'   \/><label for='answer-id-1554960' id='answer-label-1554960' class=' answer'><span>Financial disclosure<\/span><\/label><\/div><div class='watupro-question-choice  ' dir='auto' ><input type='radio' name='answer-400384[]' id='answer-id-1554961' class='answer   answerof-400384 ' value='1554961'   \/><label for='answer-id-1554961' id='answer-label-1554961' class=' answer'><span>Informed consent form<\/span><\/label><\/div><div class='watupro-question-choice  ' dir='auto' ><input type='radio' name='answer-400384[]' id='answer-id-1554962' class='answer   answerof-400384 ' value='1554962'   \/><label for='answer-id-1554962' id='answer-label-1554962' class=' answer'><span>Protocol<\/span><\/label><\/div><!-- end question-choices--><\/div><!-- end questionWrap--><\/div><\/div><div class='watu-question ' id='question-19' style=';'><div id='questionWrap-19'  class='   watupro-question-id-400385'>\n\t\t\t<div class='question-content'><div><span class='watupro_num'>19. <\/span>A PI is being considered for an industry-sponsored study. The PI sees approximately 20 patients per month who meet the study criteria. The PI does not have access to a Positron Emission Tomography (PET) scanner, which is required for the protocol. The PI is already taking part in three other studies. Should the Sponsor choose this PI?<\/div><input type='hidden' name='question_id[]' id='qID_19' value='400385' \/><input type='hidden' id='answerType400385' value='radio'><!-- end question-content--><\/div><div class='question-choices watupro-choices-columns '><div class='watupro-question-choice  ' dir='auto' ><input type='radio' name='answer-400385[]' id='answer-id-1554963' class='answer   answerof-400385 ' value='1554963'   \/><label for='answer-id-1554963' id='answer-label-1554963' class=' answer'><span>Yes, the PI has a sufficient patient population to take part in this study.<\/span><\/label><\/div><div class='watupro-question-choice  ' dir='auto' ><input type='radio' name='answer-400385[]' id='answer-id-1554964' class='answer   answerof-400385 ' value='1554964'   \/><label for='answer-id-1554964' id='answer-label-1554964' class=' answer'><span>No, the PI does not have the resources to perform all protocol-required procedures.<\/span><\/label><\/div><div class='watupro-question-choice  ' dir='auto' ><input type='radio' name='answer-400385[]' id='answer-id-1554965' class='answer   answerof-400385 ' value='1554965'   \/><label for='answer-id-1554965' id='answer-label-1554965' class=' answer'><span>Yes, the PI can perform other imaging scans instead of the PET scans.<\/span><\/label><\/div><div class='watupro-question-choice  ' dir='auto' ><input type='radio' name='answer-400385[]' id='answer-id-1554966' class='answer   answerof-400385 ' value='1554966'   \/><label for='answer-id-1554966' id='answer-label-1554966' class=' answer'><span>No, the PI is taking part in too many ongoing studies to participate in this study.<\/span><\/label><\/div><!-- end question-choices--><\/div><!-- end questionWrap--><\/div><\/div><div class='watu-question ' id='question-20' style=';'><div id='questionWrap-20'  class='   watupro-question-id-400386'>\n\t\t\t<div class='question-content'><div><span class='watupro_num'>20. <\/span>Which of the following would the sponsor need to do FIRST to set up an effective clinical trial quality management system (QMS)?<\/div><input type='hidden' name='question_id[]' id='qID_20' value='400386' \/><input type='hidden' id='answerType400386' value='radio'><!-- end question-content--><\/div><div class='question-choices watupro-choices-columns '><div class='watupro-question-choice  ' dir='auto' ><input type='radio' name='answer-400386[]' id='answer-id-1554967' class='answer   answerof-400386 ' value='1554967'   \/><label for='answer-id-1554967' id='answer-label-1554967' class=' answer'><span>Perform a periodic review to see if the quality methods are effective and relevant.<\/span><\/label><\/div><div class='watupro-question-choice  ' dir='auto' ><input type='radio' name='answer-400386[]' id='answer-id-1554968' class='answer   answerof-400386 ' value='1554968'   \/><label for='answer-id-1554968' id='answer-label-1554968' class=' answer'><span>Train the research coordinator on the required study assessments schedule.<\/span><\/label><\/div><div class='watupro-question-choice  ' dir='auto' ><input type='radio' name='answer-400386[]' id='answer-id-1554969' class='answer   answerof-400386 ' value='1554969'   \/><label for='answer-id-1554969' id='answer-label-1554969' class=' answer'><span>Determine the quality tolerance limits for data transcription errors.<\/span><\/label><\/div><div class='watupro-question-choice  ' dir='auto' ><input type='radio' name='answer-400386[]' id='answer-id-1554970' class='answer   answerof-400386 ' value='1554970'   \/><label for='answer-id-1554970' id='answer-label-1554970' class=' answer'><span>Identify critical processes and data during protocol development.<\/span><\/label><\/div><!-- end question-choices--><\/div><!-- end questionWrap--><\/div><\/div><div class='watu-question ' id='question-21' style=';'><div id='questionWrap-21'  class='   watupro-question-id-400387'>\n\t\t\t<div class='question-content'><div><span class='watupro_num'>21. <\/span>The CRC is prepared to consent a cognitively impaired participant to an Alzheimer's clinical trial. <br \/>\r<br>The CRC is required to utilize which of the following in the consent process?<\/div><input type='hidden' name='question_id[]' id='qID_21' value='400387' \/><input type='hidden' id='answerType400387' value='radio'><!-- end question-content--><\/div><div class='question-choices watupro-choices-columns '><div class='watupro-question-choice  ' dir='auto' ><input type='radio' name='answer-400387[]' id='answer-id-1554971' class='answer   answerof-400387 ' value='1554971'   \/><label for='answer-id-1554971' id='answer-label-1554971' class=' answer'><span>A witness<\/span><\/label><\/div><div class='watupro-question-choice  ' dir='auto' ><input type='radio' name='answer-400387[]' id='answer-id-1554972' class='answer   answerof-400387 ' value='1554972'   \/><label for='answer-id-1554972' id='answer-label-1554972' class=' answer'><span>A family member<\/span><\/label><\/div><div class='watupro-question-choice  ' dir='auto' ><input type='radio' name='answer-400387[]' id='answer-id-1554973' class='answer   answerof-400387 ' value='1554973'   \/><label for='answer-id-1554973' id='answer-label-1554973' class=' answer'><span>A member of the research team<\/span><\/label><\/div><div class='watupro-question-choice  ' dir='auto' ><input type='radio' name='answer-400387[]' id='answer-id-1554974' class='answer   answerof-400387 ' value='1554974'   \/><label for='answer-id-1554974' id='answer-label-1554974' class=' answer'><span>A legally acceptable representative<\/span><\/label><\/div><!-- end question-choices--><\/div><!-- end questionWrap--><\/div><\/div><div class='watu-question ' id='question-22' style=';'><div id='questionWrap-22'  class='   watupro-question-id-400388'>\n\t\t\t<div class='question-content'><div><span class='watupro_num'>22. <\/span>Who on the local site research study team is accountable for the unblinding documentation of IP?<\/div><input type='hidden' name='question_id[]' id='qID_22' value='400388' \/><input type='hidden' id='answerType400388' value='radio'><!-- end question-content--><\/div><div class='question-choices watupro-choices-columns '><div class='watupro-question-choice  ' dir='auto' ><input type='radio' name='answer-400388[]' id='answer-id-1554975' class='answer   answerof-400388 ' value='1554975'   \/><label for='answer-id-1554975' id='answer-label-1554975' class=' answer'><span>Regulatory manager<\/span><\/label><\/div><div class='watupro-question-choice  ' dir='auto' ><input type='radio' name='answer-400388[]' id='answer-id-1554976' class='answer   answerof-400388 ' value='1554976'   \/><label for='answer-id-1554976' id='answer-label-1554976' class=' answer'><span>CRC<\/span><\/label><\/div><div class='watupro-question-choice  ' dir='auto' ><input type='radio' name='answer-400388[]' id='answer-id-1554977' class='answer   answerof-400388 ' value='1554977'   \/><label for='answer-id-1554977' id='answer-label-1554977' class=' answer'><span>Pharmacist<\/span><\/label><\/div><div class='watupro-question-choice  ' dir='auto' ><input type='radio' name='answer-400388[]' id='answer-id-1554978' class='answer   answerof-400388 ' value='1554978'   \/><label for='answer-id-1554978' id='answer-label-1554978' class=' answer'><span>PI<\/span><\/label><\/div><!-- end question-choices--><\/div><!-- end questionWrap--><\/div><\/div><div class='watu-question ' id='question-23' style=';'><div id='questionWrap-23'  class='   watupro-question-id-400389'>\n\t\t\t<div class='question-content'><div><span class='watupro_num'>23. <\/span>A site is starting up a Phase III trial. They have received IRB\/IEC approval and have scheduled the SIV. <br \/>\r<br>The site cannot begin enrolling subjects until:<\/div><input type='hidden' name='question_id[]' id='qID_23' value='400389' \/><input type='hidden' id='answerType400389' value='radio'><!-- end question-content--><\/div><div class='question-choices watupro-choices-columns '><div class='watupro-question-choice  ' dir='auto' ><input type='radio' name='answer-400389[]' id='answer-id-1554979' class='answer   answerof-400389 ' value='1554979'   \/><label for='answer-id-1554979' id='answer-label-1554979' class=' answer'><span>A signed clinical trial agreement between the site and sponsor is in place.<\/span><\/label><\/div><div class='watupro-question-choice  ' dir='auto' ><input type='radio' name='answer-400389[]' id='answer-id-1554980' class='answer   answerof-400389 ' value='1554980'   \/><label for='answer-id-1554980' id='answer-label-1554980' class=' answer'><span>The site receives approval from the medical monitor to begin enrolling.<\/span><\/label><\/div><div class='watupro-question-choice  ' dir='auto' ><input type='radio' name='answer-400389[]' id='answer-id-1554981' class='answer   answerof-400389 ' value='1554981'   \/><label for='answer-id-1554981' id='answer-label-1554981' class=' answer'><span>The DSMB meets and the first DSMB meeting report has been issued.<\/span><\/label><\/div><div class='watupro-question-choice  ' dir='auto' ><input type='radio' name='answer-400389[]' id='answer-id-1554982' class='answer   answerof-400389 ' value='1554982'   \/><label for='answer-id-1554982' id='answer-label-1554982' class=' answer'><span>The CRA has performed source document review and verification at the site.<\/span><\/label><\/div><!-- end question-choices--><\/div><!-- end questionWrap--><\/div><\/div><div class='watu-question ' id='question-24' style=';'><div id='questionWrap-24'  class='   watupro-question-id-400390'>\n\t\t\t<div class='question-content'><div><span class='watupro_num'>24. <\/span>AEs that occur between study visits of a clinical trial should be evaluated by the:<\/div><input type='hidden' name='question_id[]' id='qID_24' value='400390' \/><input type='hidden' id='answerType400390' value='radio'><!-- end question-content--><\/div><div class='question-choices watupro-choices-columns '><div class='watupro-question-choice  ' dir='auto' ><input type='radio' name='answer-400390[]' id='answer-id-1554983' class='answer   answerof-400390 ' value='1554983'   \/><label for='answer-id-1554983' id='answer-label-1554983' class=' answer'><span>Subject's primary care physician<\/span><\/label><\/div><div class='watupro-question-choice  ' dir='auto' ><input type='radio' name='answer-400390[]' id='answer-id-1554984' class='answer   answerof-400390 ' value='1554984'   \/><label for='answer-id-1554984' id='answer-label-1554984' class=' answer'><span>Principal Investigator<\/span><\/label><\/div><div class='watupro-question-choice  ' dir='auto' ><input type='radio' name='answer-400390[]' id='answer-id-1554985' class='answer   answerof-400390 ' value='1554985'   \/><label for='answer-id-1554985' id='answer-label-1554985' class=' answer'><span>Medical monitor<\/span><\/label><\/div><div class='watupro-question-choice  ' dir='auto' ><input type='radio' name='answer-400390[]' id='answer-id-1554986' class='answer   answerof-400390 ' value='1554986'   \/><label for='answer-id-1554986' id='answer-label-1554986' class=' answer'><span>Study pharmacovigilance physician<\/span><\/label><\/div><!-- end question-choices--><\/div><!-- end questionWrap--><\/div><\/div><div class='watu-question ' id='question-25' style=';'><div id='questionWrap-25'  class='   watupro-question-id-400391'>\n\t\t\t<div class='question-content'><div><span class='watupro_num'>25. <\/span>The coding system for a double-blind clinical trial is accessible by the:<\/div><input type='hidden' name='question_id[]' id='qID_25' value='400391' \/><input type='hidden' id='answerType400391' value='radio'><!-- end question-content--><\/div><div class='question-choices watupro-choices-columns '><div class='watupro-question-choice  ' dir='auto' ><input type='radio' name='answer-400391[]' id='answer-id-1554987' class='answer   answerof-400391 ' value='1554987'   \/><label for='answer-id-1554987' id='answer-label-1554987' class=' answer'><span>PI<\/span><\/label><\/div><div class='watupro-question-choice  ' dir='auto' ><input type='radio' name='answer-400391[]' id='answer-id-1554988' class='answer   answerof-400391 ' value='1554988'   \/><label for='answer-id-1554988' id='answer-label-1554988' class=' answer'><span>IRB\/IEC<\/span><\/label><\/div><div class='watupro-question-choice  ' dir='auto' ><input type='radio' name='answer-400391[]' id='answer-id-1554989' class='answer   answerof-400391 ' value='1554989'   \/><label for='answer-id-1554989' id='answer-label-1554989' class=' answer'><span>Sponsor<\/span><\/label><\/div><div class='watupro-question-choice  ' dir='auto' ><input type='radio' name='answer-400391[]' id='answer-id-1554990' class='answer   answerof-400391 ' value='1554990'   \/><label for='answer-id-1554990' id='answer-label-1554990' class=' answer'><span>Regulatory authority<\/span><\/label><\/div><!-- end question-choices--><\/div><!-- end questionWrap--><\/div><\/div><div class='watu-question ' id='question-26' style=';'><div id='questionWrap-26'  class='   watupro-question-id-400392'>\n\t\t\t<div class='question-content'><div><span class='watupro_num'>26. <\/span>A Phase I drug trial has been completed and preparations are being made to proceed to a Phase II trial. <br \/>\r<br>Who is responsible for revising the IB with this updated information?<\/div><input type='hidden' name='question_id[]' id='qID_26' value='400392' \/><input type='hidden' id='answerType400392' value='radio'><!-- end question-content--><\/div><div class='question-choices watupro-choices-columns '><div class='watupro-question-choice  ' dir='auto' ><input type='radio' name='answer-400392[]' id='answer-id-1554991' class='answer   answerof-400392 ' value='1554991'   \/><label for='answer-id-1554991' id='answer-label-1554991' class=' answer'><span>Health authority<\/span><\/label><\/div><div class='watupro-question-choice  ' dir='auto' ><input type='radio' name='answer-400392[]' id='answer-id-1554992' class='answer   answerof-400392 ' value='1554992'   \/><label for='answer-id-1554992' id='answer-label-1554992' class=' answer'><span>DSMB\/IDMC<\/span><\/label><\/div><div class='watupro-question-choice  ' dir='auto' ><input type='radio' name='answer-400392[]' id='answer-id-1554993' class='answer   answerof-400392 ' value='1554993'   \/><label for='answer-id-1554993' id='answer-label-1554993' class=' answer'><span>Investigator<\/span><\/label><\/div><div class='watupro-question-choice  ' dir='auto' ><input type='radio' name='answer-400392[]' id='answer-id-1554994' class='answer   answerof-400392 ' value='1554994'   \/><label for='answer-id-1554994' id='answer-label-1554994' class=' answer'><span>Sponsor<\/span><\/label><\/div><!-- end question-choices--><\/div><!-- end questionWrap--><\/div><\/div><div class='watu-question ' id='question-27' style=';'><div id='questionWrap-27'  class='   watupro-question-id-400393'>\n\t\t\t<div class='question-content'><div><span class='watupro_num'>27. <\/span>Source data\/documentation should be:<\/div><input type='hidden' name='question_id[]' id='qID_27' value='400393' \/><input type='hidden' id='answerType400393' value='radio'><!-- end question-content--><\/div><div class='question-choices watupro-choices-columns '><div class='watupro-question-choice  ' dir='auto' ><input type='radio' name='answer-400393[]' id='answer-id-1554995' class='answer   answerof-400393 ' value='1554995'   \/><label for='answer-id-1554995' id='answer-label-1554995' class=' answer'><span>Attributable, legible, contemporaneous, original, accurate, and complete.<\/span><\/label><\/div><div class='watupro-question-choice  ' dir='auto' ><input type='radio' name='answer-400393[]' id='answer-id-1554996' class='answer   answerof-400393 ' value='1554996'   \/><label for='answer-id-1554996' id='answer-label-1554996' class=' answer'><span>Attributable, legible, contemporaneous, original, accurate, and clear.<\/span><\/label><\/div><div class='watupro-question-choice  ' dir='auto' ><input type='radio' name='answer-400393[]' id='answer-id-1554997' class='answer   answerof-400393 ' value='1554997'   \/><label for='answer-id-1554997' id='answer-label-1554997' class=' answer'><span>Attributable, legible, correct, original, accurate, and complete.<\/span><\/label><\/div><div class='watupro-question-choice  ' dir='auto' ><input type='radio' name='answer-400393[]' id='answer-id-1554998' class='answer   answerof-400393 ' value='1554998'   \/><label for='answer-id-1554998' id='answer-label-1554998' class=' answer'><span>Attributable, legible, correct, original, accurate, and clear.<\/span><\/label><\/div><!-- end question-choices--><\/div><!-- end questionWrap--><\/div><\/div><div class='watu-question ' id='question-28' style=';'><div id='questionWrap-28'  class='   watupro-question-id-400394'>\n\t\t\t<div class='question-content'><div><span class='watupro_num'>28. <\/span>Upon receiving their first dose of study drug in the clinic, the subject exhibits an immediately life-threatening reaction. The protocol prohibits any concomitant medications. <br \/>\r<br>What should be the investigator's IMMEDIATE response?<\/div><input type='hidden' name='question_id[]' id='qID_28' value='400394' \/><input type='hidden' id='answerType400394' value='radio'><!-- end question-content--><\/div><div class='question-choices watupro-choices-columns '><div class='watupro-question-choice  ' dir='auto' ><input type='radio' name='answer-400394[]' id='answer-id-1554999' class='answer   answerof-400394 ' value='1554999'   \/><label for='answer-id-1554999' id='answer-label-1554999' class=' answer'><span>Consult the I<\/span><\/label><\/div><div class='watupro-question-choice  ' dir='auto' ><input type='radio' name='answer-400394[]' id='answer-id-1555000' class='answer   answerof-400394 ' value='1555000'   \/><label for='answer-id-1555000' id='answer-label-1555000' class=' answer'><span>Call the medical monitor.<\/span><\/label><\/div><div class='watupro-question-choice  ' dir='auto' ><input type='radio' name='answer-400394[]' id='answer-id-1555001' class='answer   answerof-400394 ' value='1555001'   \/><label for='answer-id-1555001' id='answer-label-1555001' class=' answer'><span>Administer rescue medication.<\/span><\/label><\/div><div class='watupro-question-choice  ' dir='auto' ><input type='radio' name='answer-400394[]' id='answer-id-1555002' class='answer   answerof-400394 ' value='1555002'   \/><label for='answer-id-1555002' id='answer-label-1555002' class=' answer'><span>Report the AE to the sponsor.<\/span><\/label><\/div><!-- end question-choices--><\/div><!-- end questionWrap--><\/div><\/div><div class='watu-question ' id='question-29' style=';'><div id='questionWrap-29'  class='   watupro-question-id-400395'>\n\t\t\t<div class='question-content'><div><span class='watupro_num'>29. <\/span>A study subject inadvertently disposed of IP medication bottles. The site should report this to the:<\/div><input type='hidden' name='question_id[]' id='qID_29' value='400395' \/><input type='hidden' id='answerType400395' value='radio'><!-- end question-content--><\/div><div class='question-choices watupro-choices-columns '><div class='watupro-question-choice  ' dir='auto' ><input type='radio' name='answer-400395[]' id='answer-id-1555003' class='answer   answerof-400395 ' value='1555003'   \/><label for='answer-id-1555003' id='answer-label-1555003' class=' answer'><span>Sponsor.<\/span><\/label><\/div><div class='watupro-question-choice  ' dir='auto' ><input type='radio' name='answer-400395[]' id='answer-id-1555004' class='answer   answerof-400395 ' value='1555004'   \/><label for='answer-id-1555004' id='answer-label-1555004' class=' answer'><span>IRB\/IE<\/span><\/label><\/div><div class='watupro-question-choice  ' dir='auto' ><input type='radio' name='answer-400395[]' id='answer-id-1555005' class='answer   answerof-400395 ' value='1555005'   \/><label for='answer-id-1555005' id='answer-label-1555005' class=' answer'><span>Medical monitor.<\/span><\/label><\/div><div class='watupro-question-choice  ' dir='auto' ><input type='radio' name='answer-400395[]' id='answer-id-1555006' class='answer   answerof-400395 ' value='1555006'   \/><label for='answer-id-1555006' id='answer-label-1555006' class=' answer'><span>Regulatory authority.<\/span><\/label><\/div><!-- end question-choices--><\/div><!-- end questionWrap--><\/div><\/div><div class='watu-question ' id='question-30' style=';'><div id='questionWrap-30'  class='   watupro-question-id-400396'>\n\t\t\t<div class='question-content'><div><span class='watupro_num'>30. <\/span>The process of ensuring and documenting that an electronic data processing system conforms to the sponsor's established requirements for completeness, accuracy, reliability, and consistent intended performance is called:<\/div><input type='hidden' name='question_id[]' id='qID_30' value='400396' \/><input type='hidden' id='answerType400396' value='radio'><!-- end question-content--><\/div><div class='question-choices watupro-choices-columns '><div class='watupro-question-choice  ' dir='auto' ><input type='radio' name='answer-400396[]' id='answer-id-1555007' class='answer   answerof-400396 ' value='1555007'   \/><label for='answer-id-1555007' id='answer-label-1555007' class=' answer'><span>Validation<\/span><\/label><\/div><div class='watupro-question-choice  ' dir='auto' ><input type='radio' name='answer-400396[]' id='answer-id-1555008' class='answer   answerof-400396 ' value='1555008'   \/><label for='answer-id-1555008' id='answer-label-1555008' class=' answer'><span>Programming<\/span><\/label><\/div><div class='watupro-question-choice  ' dir='auto' ><input type='radio' name='answer-400396[]' id='answer-id-1555009' class='answer   answerof-400396 ' value='1555009'   \/><label for='answer-id-1555009' id='answer-label-1555009' class=' answer'><span>Quality Control<\/span><\/label><\/div><div class='watupro-question-choice  ' dir='auto' ><input type='radio' name='answer-400396[]' id='answer-id-1555010' class='answer   answerof-400396 ' value='1555010'   \/><label for='answer-id-1555010' id='answer-label-1555010' class=' answer'><span>Quality Assurance<\/span><\/label><\/div><!-- end question-choices--><\/div><!-- end questionWrap--><\/div><\/div><div class='watu-question ' id='question-31' style=';'><div id='questionWrap-31'  class='   watupro-question-id-400397'>\n\t\t\t<div class='question-content'><div><span class='watupro_num'>31. <\/span>A subject became pregnant 16 weeks into a clinical trial. She has been taking a daily dose of IP since enrollment. The baby was born missing two toes on each foot. <br \/>\r<br>How should this be reported by the site?<\/div><input type='hidden' name='question_id[]' id='qID_31' value='400397' \/><input type='hidden' id='answerType400397' value='radio'><!-- end question-content--><\/div><div class='question-choices watupro-choices-columns '><div class='watupro-question-choice  ' dir='auto' ><input type='radio' name='answer-400397[]' id='answer-id-1555011' class='answer   answerof-400397 ' value='1555011'   \/><label for='answer-id-1555011' id='answer-label-1555011' class=' answer'><span>This qualifies for expedited reporting to the sponsor.<\/span><\/label><\/div><div class='watupro-question-choice  ' dir='auto' ><input type='radio' name='answer-400397[]' id='answer-id-1555012' class='answer   answerof-400397 ' value='1555012'   \/><label for='answer-id-1555012' id='answer-label-1555012' class=' answer'><span>This needs to be reported to the patient\u2019s primary care physician.<\/span><\/label><\/div><div class='watupro-question-choice  ' dir='auto' ><input type='radio' name='answer-400397[]' id='answer-id-1555013' class='answer   answerof-400397 ' value='1555013'   \/><label for='answer-id-1555013' id='answer-label-1555013' class=' answer'><span>This qualifies for prompt reporting to the IRB\/IEC within 15 business days.<\/span><\/label><\/div><div class='watupro-question-choice  ' dir='auto' ><input type='radio' name='answer-400397[]' id='answer-id-1555014' class='answer   answerof-400397 ' value='1555014'   \/><label for='answer-id-1555014' id='answer-label-1555014' class=' answer'><span>This needs to be reported to the regulatory authorities within 10 business days.<\/span><\/label><\/div><!-- end question-choices--><\/div><!-- end questionWrap--><\/div><\/div><div class='watu-question ' id='question-32' style=';'><div id='questionWrap-32'  class='   watupro-question-id-400398'>\n\t\t\t<div class='question-content'><div><span class='watupro_num'>32. <\/span>The composition of an IDMC\/DSMB should include which one of the following?<\/div><input type='hidden' name='question_id[]' id='qID_32' value='400398' \/><input type='hidden' id='answerType400398' value='radio'><!-- end question-content--><\/div><div class='question-choices watupro-choices-columns '><div class='watupro-question-choice  ' dir='auto' ><input type='radio' name='answer-400398[]' id='answer-id-1555015' class='answer   answerof-400398 ' value='1555015'   \/><label for='answer-id-1555015' id='answer-label-1555015' class=' answer'><span>A lead PI for the study<\/span><\/label><\/div><div class='watupro-question-choice  ' dir='auto' ><input type='radio' name='answer-400398[]' id='answer-id-1555016' class='answer   answerof-400398 ' value='1555016'   \/><label for='answer-id-1555016' id='answer-label-1555016' class=' answer'><span>A member from the IRB\/IEC<\/span><\/label><\/div><div class='watupro-question-choice  ' dir='auto' ><input type='radio' name='answer-400398[]' id='answer-id-1555017' class='answer   answerof-400398 ' value='1555017'   \/><label for='answer-id-1555017' id='answer-label-1555017' class=' answer'><span>A clinical scientist who is knowledgeable in the appropriate discipline<\/span><\/label><\/div><div class='watupro-question-choice  ' dir='auto' ><input type='radio' name='answer-400398[]' id='answer-id-1555018' class='answer   answerof-400398 ' value='1555018'   \/><label for='answer-id-1555018' id='answer-label-1555018' class=' answer'><span>A sponsor representative who is knowledgeable about the study\u2019s unblinded information<\/span><\/label><\/div><!-- end question-choices--><\/div><!-- end questionWrap--><\/div><\/div><div class='watu-question ' id='question-33' style=';'><div id='questionWrap-33'  class='   watupro-question-id-400399'>\n\t\t\t<div class='question-content'><div><span class='watupro_num'>33. <\/span>A monitor identifies multiple deviations from a protocol-defined timeline for study procedures. The monitor is unable to identify proof of PI review and assessment of the deviations. The monitor discusses the deviations with the PI, who initiates a CAPA. <br \/>\r<br>What is the purpose of this CAPA?<\/div><input type='hidden' name='question_id[]' id='qID_33' value='400399' \/><input type='hidden' id='answerType400399' value='radio'><!-- end question-content--><\/div><div class='question-choices watupro-choices-columns '><div class='watupro-question-choice  ' dir='auto' ><input type='radio' name='answer-400399[]' id='answer-id-1555019' class='answer   answerof-400399 ' value='1555019'   \/><label for='answer-id-1555019' id='answer-label-1555019' class=' answer'><span>To determine if a protocol amendment is needed<\/span><\/label><\/div><div class='watupro-question-choice  ' dir='auto' ><input type='radio' name='answer-400399[]' id='answer-id-1555020' class='answer   answerof-400399 ' value='1555020'   \/><label for='answer-id-1555020' id='answer-label-1555020' class=' answer'><span>To escalate corrective actions to the regulatory authority<\/span><\/label><\/div><div class='watupro-question-choice  ' dir='auto' ><input type='radio' name='answer-400399[]' id='answer-id-1555021' class='answer   answerof-400399 ' value='1555021'   \/><label for='answer-id-1555021' id='answer-label-1555021' class=' answer'><span>To determine if the deviations invalidate the data<\/span><\/label><\/div><div class='watupro-question-choice  ' dir='auto' ><input type='radio' name='answer-400399[]' id='answer-id-1555022' class='answer   answerof-400399 ' value='1555022'   \/><label for='answer-id-1555022' id='answer-label-1555022' class=' answer'><span>To establish a procedure for PI oversight of protocol deviations<\/span><\/label><\/div><!-- end question-choices--><\/div><!-- end questionWrap--><\/div><\/div><div class='watu-question ' id='question-34' style=';'><div id='questionWrap-34'  class='   watupro-question-id-400400'>\n\t\t\t<div class='question-content'><div><span class='watupro_num'>34. <\/span>The sponsor must report a serious unexpected AE to the regulatory authorities within a maximum of:<\/div><input type='hidden' name='question_id[]' id='qID_34' value='400400' \/><input type='hidden' id='answerType400400' value='radio'><!-- end question-content--><\/div><div class='question-choices watupro-choices-columns '><div class='watupro-question-choice  ' dir='auto' ><input type='radio' name='answer-400400[]' id='answer-id-1555023' class='answer   answerof-400400 ' value='1555023'   \/><label for='answer-id-1555023' id='answer-label-1555023' class=' answer'><span>7 calendar days<\/span><\/label><\/div><div class='watupro-question-choice  ' dir='auto' ><input type='radio' name='answer-400400[]' id='answer-id-1555024' class='answer   answerof-400400 ' value='1555024'   \/><label for='answer-id-1555024' id='answer-label-1555024' class=' answer'><span>8 calendar days<\/span><\/label><\/div><div class='watupro-question-choice  ' dir='auto' ><input type='radio' name='answer-400400[]' id='answer-id-1555025' class='answer   answerof-400400 ' value='1555025'   \/><label for='answer-id-1555025' id='answer-label-1555025' class=' answer'><span>15 calendar days<\/span><\/label><\/div><div class='watupro-question-choice  ' dir='auto' ><input type='radio' name='answer-400400[]' id='answer-id-1555026' class='answer   answerof-400400 ' value='1555026'   \/><label for='answer-id-1555026' id='answer-label-1555026' class=' answer'><span>30 calendar days<\/span><\/label><\/div><!-- end question-choices--><\/div><!-- end questionWrap--><\/div><\/div><div class='watu-question ' id='question-35' style=';'><div id='questionWrap-35'  class='   watupro-question-id-400401'>\n\t\t\t<div class='question-content'><div><span class='watupro_num'>35. <\/span>In preparation for an upcoming site audit, whose responsibility is it to ensure study-related functions were conducted by qualified personnel?<\/div><input type='hidden' name='question_id[]' id='qID_35' value='400401' \/><input type='hidden' id='answerType400401' value='radio'><!-- end question-content--><\/div><div class='question-choices watupro-choices-columns '><div class='watupro-question-choice  ' dir='auto' ><input type='radio' name='answer-400401[]' id='answer-id-1555027' class='answer   answerof-400401 ' value='1555027'   \/><label for='answer-id-1555027' id='answer-label-1555027' class=' answer'><span>Investigator<\/span><\/label><\/div><div class='watupro-question-choice  ' dir='auto' ><input type='radio' name='answer-400401[]' id='answer-id-1555028' class='answer   answerof-400401 ' value='1555028'   \/><label for='answer-id-1555028' id='answer-label-1555028' class=' answer'><span>CRA<\/span><\/label><\/div><div class='watupro-question-choice  ' dir='auto' ><input type='radio' name='answer-400401[]' id='answer-id-1555029' class='answer   answerof-400401 ' value='1555029'   \/><label for='answer-id-1555029' id='answer-label-1555029' class=' answer'><span>Sponsor<\/span><\/label><\/div><div class='watupro-question-choice  ' dir='auto' ><input type='radio' name='answer-400401[]' id='answer-id-1555030' class='answer   answerof-400401 ' value='1555030'   \/><label for='answer-id-1555030' id='answer-label-1555030' class=' answer'><span>CRC<\/span><\/label><\/div><!-- end question-choices--><\/div><!-- end questionWrap--><\/div><\/div><div class='watu-question ' id='question-36' style=';'><div id='questionWrap-36'  class='   watupro-question-id-400402'>\n\t\t\t<div class='question-content'><div><span class='watupro_num'>36. <\/span>All of the following are examples of what monitors review EXCEPT:<\/div><input type='hidden' name='question_id[]' id='qID_36' value='400402' \/><input type='hidden' id='answerType400402' value='radio'><!-- end question-content--><\/div><div class='question-choices watupro-choices-columns '><div class='watupro-question-choice  ' dir='auto' ><input type='radio' name='answer-400402[]' id='answer-id-1555031' class='answer   answerof-400402 ' value='1555031'   \/><label for='answer-id-1555031' id='answer-label-1555031' class=' answer'><span>Regulatory binder which includes copies of current certifications for all laboratories.<\/span><\/label><\/div><div class='watupro-question-choice  ' dir='auto' ><input type='radio' name='answer-400402[]' id='answer-id-1555032' class='answer   answerof-400402 ' value='1555032'   \/><label for='answer-id-1555032' id='answer-label-1555032' class=' answer'><span>The signed ICF retained in the participant's study file.<\/span><\/label><\/div><div class='watupro-question-choice  ' dir='auto' ><input type='radio' name='answer-400402[]' id='answer-id-1555033' class='answer   answerof-400402 ' value='1555033'   \/><label for='answer-id-1555033' id='answer-label-1555033' class=' answer'><span>Potential patient medical records for eligibility prior to the informed consent process.<\/span><\/label><\/div><div class='watupro-question-choice  ' dir='auto' ><input type='radio' name='answer-400402[]' id='answer-id-1555034' class='answer   answerof-400402 ' value='1555034'   \/><label for='answer-id-1555034' id='answer-label-1555034' class=' answer'><span>Documentation in the participant's medical record of study drug administration.<\/span><\/label><\/div><!-- end question-choices--><\/div><!-- end questionWrap--><\/div><\/div><div class='watu-question ' id='question-37' style=';'><div id='questionWrap-37'  class='   watupro-question-id-400403'>\n\t\t\t<div class='question-content'><div><span class='watupro_num'>37. <\/span>A serious unexpected ADR is one:<\/div><input type='hidden' name='question_id[]' id='qID_37' value='400403' \/><input type='hidden' id='answerType400403' value='radio'><!-- end question-content--><\/div><div class='question-choices watupro-choices-columns '><div class='watupro-question-choice  ' dir='auto' ><input type='radio' name='answer-400403[]' id='answer-id-1555035' class='answer   answerof-400403 ' value='1555035'   \/><label for='answer-id-1555035' id='answer-label-1555035' class=' answer'><span>Severity and nature of the reaction is consistent with protocol.<\/span><\/label><\/div><div class='watupro-question-choice  ' dir='auto' ><input type='radio' name='answer-400403[]' id='answer-id-1555036' class='answer   answerof-400403 ' value='1555036'   \/><label for='answer-id-1555036' id='answer-label-1555036' class=' answer'><span>Where the severity of the reaction is not consistent with I<\/span><\/label><\/div><div class='watupro-question-choice  ' dir='auto' ><input type='radio' name='answer-400403[]' id='answer-id-1555037' class='answer   answerof-400403 ' value='1555037'   \/><label for='answer-id-1555037' id='answer-label-1555037' class=' answer'><span>That does not need to be reported to the IRB\/IE<\/span><\/label><\/div><div class='watupro-question-choice  ' dir='auto' ><input type='radio' name='answer-400403[]' id='answer-id-1555038' class='answer   answerof-400403 ' value='1555038'   \/><label for='answer-id-1555038' id='answer-label-1555038' class=' answer'><span>That results in the death of the subject.<\/span><\/label><\/div><!-- end question-choices--><\/div><!-- end questionWrap--><\/div><\/div><div class='watu-question ' id='question-38' style=';'><div id='questionWrap-38'  class='   watupro-question-id-400404'>\n\t\t\t<div class='question-content'><div><span class='watupro_num'>38. <\/span>The investigator\/institution should permit:<\/div><input type='hidden' name='question_id[]' id='qID_38' value='400404' \/><input type='hidden' id='answerType400404' value='radio'><!-- end question-content--><\/div><div class='question-choices watupro-choices-columns '><div class='watupro-question-choice  ' dir='auto' ><input type='radio' name='answer-400404[]' id='answer-id-1555039' class='answer   answerof-400404 ' value='1555039'   \/><label for='answer-id-1555039' id='answer-label-1555039' class=' answer'><span>Monitoring and inspection by the appropriate regulatory authority(ies), and auditing by the sponsor.<\/span><\/label><\/div><div class='watupro-question-choice  ' dir='auto' ><input type='radio' name='answer-400404[]' id='answer-id-1555040' class='answer   answerof-400404 ' value='1555040'   \/><label for='answer-id-1555040' id='answer-label-1555040' class=' answer'><span>Monitoring and inspection by the sponsor, and auditing by the appropriate regulatory authority(ies).<\/span><\/label><\/div><div class='watupro-question-choice  ' dir='auto' ><input type='radio' name='answer-400404[]' id='answer-id-1555041' class='answer   answerof-400404 ' value='1555041'   \/><label for='answer-id-1555041' id='answer-label-1555041' class=' answer'><span>Monitoring and auditing by the appropriate regulatory authority(ies), and inspection by the sponsor.<\/span><\/label><\/div><div class='watupro-question-choice  ' dir='auto' ><input type='radio' name='answer-400404[]' id='answer-id-1555042' class='answer   answerof-400404 ' value='1555042'   \/><label for='answer-id-1555042' id='answer-label-1555042' class=' answer'><span>Monitoring and auditing by the sponsor, and inspection by the appropriate regulatory authority(ies).<\/span><\/label><\/div><!-- end question-choices--><\/div><!-- end questionWrap--><\/div><\/div><div class='watu-question ' id='question-39' style=';'><div id='questionWrap-39'  class='   watupro-question-id-400405'>\n\t\t\t<div class='question-content'><div><span class='watupro_num'>39. <\/span>An investigator participating in a multicenter clinical trial has had 2 of the 4 subjects admitted to the emergency room for life-threatening infections. The investigator made the decision to stop treatment with IP and test for infections in the remaining subjects. <br \/>\r<br>What are the NEXT steps the investigator should take?<\/div><input type='hidden' name='question_id[]' id='qID_39' value='400405' \/><input type='hidden' id='answerType400405' value='radio'><!-- end question-content--><\/div><div class='question-choices watupro-choices-columns '><div class='watupro-question-choice  ' dir='auto' ><input type='radio' name='answer-400405[]' id='answer-id-1555043' class='answer   answerof-400405 ' value='1555043'   \/><label for='answer-id-1555043' id='answer-label-1555043' class=' answer'><span>Add the risk of infection to the ICF and submit to the IRB\/IEC for review.<\/span><\/label><\/div><div class='watupro-question-choice  ' dir='auto' ><input type='radio' name='answer-400405[]' id='answer-id-1555044' class='answer   answerof-400405 ' value='1555044'   \/><label for='answer-id-1555044' id='answer-label-1555044' class=' answer'><span>Update the IB to add the risk of infection and submit to the sponsor for approval.<\/span><\/label><\/div><div class='watupro-question-choice  ' dir='auto' ><input type='radio' name='answer-400405[]' id='answer-id-1555045' class='answer   answerof-400405 ' value='1555045'   \/><label for='answer-id-1555045' id='answer-label-1555045' class=' answer'><span>Notify the sponsor of the change in study plan and submit the deviation to the IRB\/IEC for review.<\/span><\/label><\/div><div class='watupro-question-choice  ' dir='auto' ><input type='radio' name='answer-400405[]' id='answer-id-1555046' class='answer   answerof-400405 ' value='1555046'   \/><label for='answer-id-1555046' id='answer-label-1555046' class=' answer'><span>Discontinue current subjects from the study and monitor subjects for any anticipated safety events.<\/span><\/label><\/div><!-- end question-choices--><\/div><!-- end questionWrap--><\/div><\/div><div class='watu-question ' id='question-40' style=';'><div id='questionWrap-40'  class='   watupro-question-id-400406'>\n\t\t\t<div class='question-content'><div><span class='watupro_num'>40. <\/span>The sponsor should supply a PI with the IP after:<\/div><input type='hidden' name='question_id[]' id='qID_40' value='400406' \/><input type='hidden' id='answerType400406' value='radio'><!-- end question-content--><\/div><div class='question-choices watupro-choices-columns '><div class='watupro-question-choice  ' dir='auto' ><input type='radio' name='answer-400406[]' id='answer-id-1555047' class='answer   answerof-400406 ' value='1555047'   \/><label for='answer-id-1555047' id='answer-label-1555047' class=' answer'><span>Approval of protocol by the sponsor.<\/span><\/label><\/div><div class='watupro-question-choice  ' dir='auto' ><input type='radio' name='answer-400406[]' id='answer-id-1555048' class='answer   answerof-400406 ' value='1555048'   \/><label for='answer-id-1555048' id='answer-label-1555048' class=' answer'><span>Approval\/favorable opinion from IRB\/IEC and regulatory authority.<\/span><\/label><\/div><div class='watupro-question-choice  ' dir='auto' ><input type='radio' name='answer-400406[]' id='answer-id-1555049' class='answer   answerof-400406 ' value='1555049'   \/><label for='answer-id-1555049' id='answer-label-1555049' class=' answer'><span>Submission of documents to IRB\/IEC and regulatory authority for review.<\/span><\/label><\/div><div class='watupro-question-choice  ' dir='auto' ><input type='radio' name='answer-400406[]' id='answer-id-1555050' class='answer   answerof-400406 ' value='1555050'   \/><label for='answer-id-1555050' id='answer-label-1555050' class=' answer'><span>Approval of protocol by the P<\/span><\/label><\/div><!-- end question-choices--><\/div><!-- end questionWrap--><\/div><\/div><div class='watu-question ' id='question-41' style=';'><div id='questionWrap-41'  class='   watupro-question-id-400407'>\n\t\t\t<div class='question-content'><div><span class='watupro_num'>41. <\/span>A root cause analysis should be:<\/div><input type='hidden' name='question_id[]' id='qID_41' value='400407' \/><input type='hidden' id='answerType400407' value='radio'><!-- end question-content--><\/div><div class='question-choices watupro-choices-columns '><div class='watupro-question-choice  ' dir='auto' ><input type='radio' name='answer-400407[]' id='answer-id-1555051' class='answer   answerof-400407 ' value='1555051'   \/><label for='answer-id-1555051' id='answer-label-1555051' class=' answer'><span>Specific to a clinical trial.<\/span><\/label><\/div><div class='watupro-question-choice  ' dir='auto' ><input type='radio' name='answer-400407[]' id='answer-id-1555052' class='answer   answerof-400407 ' value='1555052'   \/><label for='answer-id-1555052' id='answer-label-1555052' class=' answer'><span>Written by the investigator.<\/span><\/label><\/div><div class='watupro-question-choice  ' dir='auto' ><input type='radio' name='answer-400407[]' id='answer-id-1555053' class='answer   answerof-400407 ' value='1555053'   \/><label for='answer-id-1555053' id='answer-label-1555053' class=' answer'><span>Validated before use in a CAP<\/span><\/label><\/div><div class='watupro-question-choice  ' dir='auto' ><input type='radio' name='answer-400407[]' id='answer-id-1555054' class='answer   answerof-400407 ' value='1555054'   \/><label for='answer-id-1555054' id='answer-label-1555054' class=' answer'><span>Focused on issues of non-compliance.<\/span><\/label><\/div><!-- end question-choices--><\/div><!-- end questionWrap--><\/div><\/div><div class='watu-question ' id='question-42' style=';'><div id='questionWrap-42'  class='   watupro-question-id-400408'>\n\t\t\t<div class='question-content'><div><span class='watupro_num'>42. <\/span>Which of the following elements of the Informed Consent are NOT required?<\/div><input type='hidden' name='question_id[]' id='qID_42' value='400408' \/><input type='hidden' id='answerType400408' value='radio'><!-- end question-content--><\/div><div class='question-choices watupro-choices-columns '><div class='watupro-question-choice  ' dir='auto' ><input type='radio' name='answer-400408[]' id='answer-id-1555055' class='answer   answerof-400408 ' value='1555055'   \/><label for='answer-id-1555055' id='answer-label-1555055' class=' answer'><span>A description of any reasonably foreseeable risks or discomforts<\/span><\/label><\/div><div class='watupro-question-choice  ' dir='auto' ><input type='radio' name='answer-400408[]' id='answer-id-1555056' class='answer   answerof-400408 ' value='1555056'   \/><label for='answer-id-1555056' id='answer-label-1555056' class=' answer'><span>Statement that study involves research<\/span><\/label><\/div><div class='watupro-question-choice  ' dir='auto' ><input type='radio' name='answer-400408[]' id='answer-id-1555057' class='answer   answerof-400408 ' value='1555057'   \/><label for='answer-id-1555057' id='answer-label-1555057' class=' answer'><span>A description of potential benefits<\/span><\/label><\/div><div class='watupro-question-choice  ' dir='auto' ><input type='radio' name='answer-400408[]' id='answer-id-1555058' class='answer   answerof-400408 ' value='1555058'   \/><label for='answer-id-1555058' id='answer-label-1555058' class=' answer'><span>Subject legal rights can be waived<\/span><\/label><\/div><!-- end question-choices--><\/div><!-- end questionWrap--><\/div><\/div><div class='watu-question ' id='question-43' style=';'><div id='questionWrap-43'  class='   watupro-question-id-400409'>\n\t\t\t<div class='question-content'><div><span class='watupro_num'>43. <\/span>An impartial witness should be present during the entire informed consent discussion when:<\/div><input type='hidden' name='question_id[]' id='qID_43' value='400409' \/><input type='hidden' id='answerType400409' value='radio'><!-- end question-content--><\/div><div class='question-choices watupro-choices-columns '><div class='watupro-question-choice  ' dir='auto' ><input type='radio' name='answer-400409[]' id='answer-id-1555059' class='answer   answerof-400409 ' value='1555059'   \/><label for='answer-id-1555059' id='answer-label-1555059' class=' answer'><span>A subject has been determined to be vulnerable.<\/span><\/label><\/div><div class='watupro-question-choice  ' dir='auto' ><input type='radio' name='answer-400409[]' id='answer-id-1555060' class='answer   answerof-400409 ' value='1555060'   \/><label for='answer-id-1555060' id='answer-label-1555060' class=' answer'><span>A parent\/guardian is consenting for a minor subject.<\/span><\/label><\/div><div class='watupro-question-choice  ' dir='auto' ><input type='radio' name='answer-400409[]' id='answer-id-1555061' class='answer   answerof-400409 ' value='1555061'   \/><label for='answer-id-1555061' id='answer-label-1555061' class=' answer'><span>A legally acceptable representative is unable to read.<\/span><\/label><\/div><div class='watupro-question-choice  ' dir='auto' ><input type='radio' name='answer-400409[]' id='answer-id-1555062' class='answer   answerof-400409 ' value='1555062'   \/><label for='answer-id-1555062' id='answer-label-1555062' class=' answer'><span>An interpreter is translating the consent form for a subject.<\/span><\/label><\/div><!-- end question-choices--><\/div><!-- end questionWrap--><\/div><\/div><div class='watu-question ' id='question-44' style=';'><div id='questionWrap-44'  class='   watupro-question-id-400410'>\n\t\t\t<div class='question-content'><div><span class='watupro_num'>44. <\/span>A sponsor writes a protocol comparing an IP XYZ to a marketed drug ABC to determine if XYZ is more efficacious in the target population than ABC. Both drugs are prepared in identically masked IV bags and distributed according to the randomization scheme outlined in the protocol such that the study team is unaware of the treatment assignment. <br \/>\r<br>Which of the following is an appropriate title for this study?<\/div><input type='hidden' name='question_id[]' id='qID_44' value='400410' \/><input type='hidden' id='answerType400410' value='radio'><!-- end question-content--><\/div><div class='question-choices watupro-choices-columns '><div class='watupro-question-choice  ' dir='auto' ><input type='radio' name='answer-400410[]' id='answer-id-1555063' class='answer   answerof-400410 ' value='1555063'   \/><label for='answer-id-1555063' id='answer-label-1555063' class=' answer'><span>A randomized, single-blind, placebo-controlled study comparing the efficacy of XYZ to ABC in the target population<\/span><\/label><\/div><div class='watupro-question-choice  ' dir='auto' ><input type='radio' name='answer-400410[]' id='answer-id-1555064' class='answer   answerof-400410 ' value='1555064'   \/><label for='answer-id-1555064' id='answer-label-1555064' class=' answer'><span>A randomized, double-blind, superiority study comparing the efficacy of XYZ to ABC in the target population<\/span><\/label><\/div><div class='watupro-question-choice  ' dir='auto' ><input type='radio' name='answer-400410[]' id='answer-id-1555065' class='answer   answerof-400410 ' value='1555065'   \/><label for='answer-id-1555065' id='answer-label-1555065' class=' answer'><span>A randomized, open-label, comparator study comparing the efficacy of XYZ to ABC in the target population<\/span><\/label><\/div><div class='watupro-question-choice  ' dir='auto' ><input type='radio' name='answer-400410[]' id='answer-id-1555066' class='answer   answerof-400410 ' value='1555066'   \/><label for='answer-id-1555066' id='answer-label-1555066' class=' answer'><span>A randomized, double-blind, double-dummy, superiority study comparing the efficacy of XYZ to ABC in the target population<\/span><\/label><\/div><!-- end question-choices--><\/div><!-- end questionWrap--><\/div><\/div><div class='watu-question ' id='question-45' style=';'><div id='questionWrap-45'  class='   watupro-question-id-400411'>\n\t\t\t<div class='question-content'><div><span class='watupro_num'>45. <\/span>Who is responsible for outlining written procedures in a study to assure that changes or corrections in CRFs are documented, are necessary, and are endorsed by the investigator?<\/div><input type='hidden' name='question_id[]' id='qID_45' value='400411' \/><input type='hidden' id='answerType400411' value='radio'><!-- end question-content--><\/div><div class='question-choices watupro-choices-columns '><div class='watupro-question-choice  ' dir='auto' ><input type='radio' name='answer-400411[]' id='answer-id-1555067' class='answer   answerof-400411 ' value='1555067'   \/><label for='answer-id-1555067' id='answer-label-1555067' class=' answer'><span>CRA<\/span><\/label><\/div><div class='watupro-question-choice  ' dir='auto' ><input type='radio' name='answer-400411[]' id='answer-id-1555068' class='answer   answerof-400411 ' value='1555068'   \/><label for='answer-id-1555068' id='answer-label-1555068' class=' answer'><span>CRO<\/span><\/label><\/div><div class='watupro-question-choice  ' dir='auto' ><input type='radio' name='answer-400411[]' id='answer-id-1555069' class='answer   answerof-400411 ' value='1555069'   \/><label for='answer-id-1555069' id='answer-label-1555069' class=' answer'><span>Sponsor<\/span><\/label><\/div><div class='watupro-question-choice  ' dir='auto' ><input type='radio' name='answer-400411[]' id='answer-id-1555070' class='answer   answerof-400411 ' value='1555070'   \/><label for='answer-id-1555070' id='answer-label-1555070' class=' answer'><span>Data Manager<\/span><\/label><\/div><!-- end question-choices--><\/div><!-- end questionWrap--><\/div><\/div><div class='watu-question ' id='question-46' style=';'><div id='questionWrap-46'  class='   watupro-question-id-400412'>\n\t\t\t<div class='question-content'><div><span class='watupro_num'>46. <\/span>Who ensures information regarding payments to subjects is documented in a written consent form?<\/div><input type='hidden' name='question_id[]' id='qID_46' value='400412' \/><input type='hidden' id='answerType400412' value='radio'><!-- end question-content--><\/div><div class='question-choices watupro-choices-columns '><div class='watupro-question-choice  ' dir='auto' ><input type='radio' name='answer-400412[]' id='answer-id-1555071' class='answer   answerof-400412 ' value='1555071'   \/><label for='answer-id-1555071' id='answer-label-1555071' class=' answer'><span>Coordinator<\/span><\/label><\/div><div class='watupro-question-choice  ' dir='auto' ><input type='radio' name='answer-400412[]' id='answer-id-1555072' class='answer   answerof-400412 ' value='1555072'   \/><label for='answer-id-1555072' id='answer-label-1555072' class=' answer'><span>IRB\/IEC<\/span><\/label><\/div><div class='watupro-question-choice  ' dir='auto' ><input type='radio' name='answer-400412[]' id='answer-id-1555073' class='answer   answerof-400412 ' value='1555073'   \/><label for='answer-id-1555073' id='answer-label-1555073' class=' answer'><span>PI<\/span><\/label><\/div><div class='watupro-question-choice  ' dir='auto' ><input type='radio' name='answer-400412[]' id='answer-id-1555074' class='answer   answerof-400412 ' value='1555074'   \/><label for='answer-id-1555074' id='answer-label-1555074' class=' answer'><span>Sponsor<\/span><\/label><\/div><!-- end question-choices--><\/div><!-- end questionWrap--><\/div><\/div><div class='watu-question ' id='question-47' style=';'><div id='questionWrap-47'  class='   watupro-question-id-400413'>\n\t\t\t<div class='question-content'><div><span class='watupro_num'>47. <\/span>A sponsor wants to transfer duties to a CRO. <br \/>\r<br>Which of the following statements is the MOST correct?<\/div><input type='hidden' name='question_id[]' id='qID_47' value='400413' \/><input type='hidden' id='answerType400413' value='radio'><!-- end question-content--><\/div><div class='question-choices watupro-choices-columns '><div class='watupro-question-choice  ' dir='auto' ><input type='radio' name='answer-400413[]' id='answer-id-1555075' class='answer   answerof-400413 ' value='1555075'   \/><label for='answer-id-1555075' id='answer-label-1555075' class=' answer'><span>The IRB\/IEC must approve the transfer of duties to a CR<\/span><\/label><\/div><div class='watupro-question-choice  ' dir='auto' ><input type='radio' name='answer-400413[]' id='answer-id-1555076' class='answer   answerof-400413 ' value='1555076'   \/><label for='answer-id-1555076' id='answer-label-1555076' class=' answer'><span>All duties transferred to a CRO should be specified in writing.<\/span><\/label><\/div><div class='watupro-question-choice  ' dir='auto' ><input type='radio' name='answer-400413[]' id='answer-id-1555077' class='answer   answerof-400413 ' value='1555077'   \/><label for='answer-id-1555077' id='answer-label-1555077' class=' answer'><span>Any trial-related duties can be documented as transferred by verbal agreement.<\/span><\/label><\/div><div class='watupro-question-choice  ' dir='auto' ><input type='radio' name='answer-400413[]' id='answer-id-1555078' class='answer   answerof-400413 ' value='1555078'   \/><label for='answer-id-1555078' id='answer-label-1555078' class=' answer'><span>Regulatory authorities must be notified promptly of the transfer of any duties to a CR<\/span><\/label><\/div><!-- end question-choices--><\/div><!-- end questionWrap--><\/div><\/div><div class='watu-question ' id='question-48' style=';'><div id='questionWrap-48'  class='   watupro-question-id-400414'>\n\t\t\t<div class='question-content'><div><span class='watupro_num'>48. <\/span>Who takes responsibility for initiating a clinical trial?<\/div><input type='hidden' name='question_id[]' id='qID_48' value='400414' \/><input type='hidden' id='answerType400414' value='radio'><!-- end question-content--><\/div><div class='question-choices watupro-choices-columns '><div class='watupro-question-choice  ' dir='auto' ><input type='radio' name='answer-400414[]' id='answer-id-1555079' class='answer   answerof-400414 ' value='1555079'   \/><label for='answer-id-1555079' id='answer-label-1555079' class=' answer'><span>CRO<\/span><\/label><\/div><div class='watupro-question-choice  ' dir='auto' ><input type='radio' name='answer-400414[]' id='answer-id-1555080' class='answer   answerof-400414 ' value='1555080'   \/><label for='answer-id-1555080' id='answer-label-1555080' class=' answer'><span>Investigator<\/span><\/label><\/div><div class='watupro-question-choice  ' dir='auto' ><input type='radio' name='answer-400414[]' id='answer-id-1555081' class='answer   answerof-400414 ' value='1555081'   \/><label for='answer-id-1555081' id='answer-label-1555081' class=' answer'><span>IRB\/IEC<\/span><\/label><\/div><div class='watupro-question-choice  ' dir='auto' ><input type='radio' name='answer-400414[]' id='answer-id-1555082' class='answer   answerof-400414 ' value='1555082'   \/><label for='answer-id-1555082' id='answer-label-1555082' class=' answer'><span>Sponsor<\/span><\/label><\/div><!-- end question-choices--><\/div><!-- end questionWrap--><\/div><\/div><div class='watu-question ' id='question-49' style=';'><div id='questionWrap-49'  class='   watupro-question-id-400415'>\n\t\t\t<div class='question-content'><div><span class='watupro_num'>49. <\/span>An audit was recently completed and identified non-compliance that could potentially affect the reliability of study results. <br \/>\r<br>Who should perform a root cause analysis and implement appropriate corrective and preventive actions?<\/div><input type='hidden' name='question_id[]' id='qID_49' value='400415' \/><input type='hidden' id='answerType400415' value='radio'><!-- end question-content--><\/div><div class='question-choices watupro-choices-columns '><div class='watupro-question-choice  ' dir='auto' ><input type='radio' name='answer-400415[]' id='answer-id-1555083' class='answer   answerof-400415 ' value='1555083'   \/><label for='answer-id-1555083' id='answer-label-1555083' class=' answer'><span>Sponsor<\/span><\/label><\/div><div class='watupro-question-choice  ' dir='auto' ><input type='radio' name='answer-400415[]' id='answer-id-1555084' class='answer   answerof-400415 ' value='1555084'   \/><label for='answer-id-1555084' id='answer-label-1555084' class=' answer'><span>PI<\/span><\/label><\/div><div class='watupro-question-choice  ' dir='auto' ><input type='radio' name='answer-400415[]' id='answer-id-1555085' class='answer   answerof-400415 ' value='1555085'   \/><label for='answer-id-1555085' id='answer-label-1555085' class=' answer'><span>IRB\/IEC<\/span><\/label><\/div><div class='watupro-question-choice  ' dir='auto' ><input type='radio' name='answer-400415[]' id='answer-id-1555086' class='answer   answerof-400415 ' value='1555086'   \/><label for='answer-id-1555086' id='answer-label-1555086' class=' answer'><span>DSMB\/IDMC<\/span><\/label><\/div><!-- end question-choices--><\/div><!-- end questionWrap--><\/div><\/div><div class='watu-question ' id='question-50' style=';'><div id='questionWrap-50'  class='   watupro-question-id-400416'>\n\t\t\t<div class='question-content'><div><span class='watupro_num'>50. <\/span>A protocol requires participants to take 1 tablet of IP per day. At each visit, participants are supplied with enough IP for 35 days. They are asked to return any unused IP at the next visit. One participant returns at the 1-month visit at 30 days with 10 tablets of unused IP and at the 2-month visit at 60 days with 12 tablets of unused IP. <br \/>\r<br>What is the participant\u2019s overall compliance?<\/div><input type='hidden' name='question_id[]' id='qID_50' value='400416' \/><input type='hidden' id='answerType400416' value='radio'><!-- end question-content--><\/div><div class='question-choices watupro-choices-columns '><div class='watupro-question-choice  ' dir='auto' ><input type='radio' name='answer-400416[]' id='answer-id-1555087' class='answer   answerof-400416 ' value='1555087'   \/><label for='answer-id-1555087' id='answer-label-1555087' class=' answer'><span>66%<\/span><\/label><\/div><div class='watupro-question-choice  ' dir='auto' ><input type='radio' name='answer-400416[]' id='answer-id-1555088' class='answer   answerof-400416 ' value='1555088'   \/><label for='answer-id-1555088' id='answer-label-1555088' class=' answer'><span>71%<\/span><\/label><\/div><div class='watupro-question-choice  ' dir='auto' ><input type='radio' name='answer-400416[]' id='answer-id-1555089' class='answer   answerof-400416 ' value='1555089'   \/><label for='answer-id-1555089' id='answer-label-1555089' class=' answer'><span>77%<\/span><\/label><\/div><div class='watupro-question-choice  ' dir='auto' ><input type='radio' name='answer-400416[]' id='answer-id-1555090' class='answer   answerof-400416 ' value='1555090'   \/><label for='answer-id-1555090' id='answer-label-1555090' class=' answer'><span>80%<\/span><\/label><\/div><!-- end question-choices--><\/div><!-- end questionWrap--><\/div><\/div><div style='display:none' id='question-51'>\n\t<div class='question-content'>\n\t\t<img loading=\"lazy\" decoding=\"async\" src=\"https:\/\/www.dumpsbase.com\/freedumps\/wp-content\/plugins\/watupro\/img\/loading.gif\" width=\"16\" height=\"16\" alt=\"Loading...\" title=\"Loading...\" \/>&nbsp;Loading...\t<\/div>\n<\/div>\n\n<br \/>\n\t\n\t\t\t<div class=\"watupro_buttons flex \" id=\"watuPROButtons10077\" >\n\t\t  <div id=\"prev-question\" style=\"display:none;\"><input type=\"button\" value=\"&lt; Previous\" onclick=\"WatuPRO.nextQuestion(event, 'previous');\"\/><\/div>\t\t  \t\t  \t\t   \n\t\t   \t  \t\t<div><input type=\"button\" name=\"action\" class=\"watupro-submit-button\" onclick=\"WatuPRO.submitResult(event)\" id=\"action-button\" value=\"View Results\"  \/>\n\t\t<\/div>\n\t\t<\/div>\n\t\t\n\t<input type=\"hidden\" name=\"quiz_id\" value=\"10077\" id=\"watuPROExamID\"\/>\n\t<input type=\"hidden\" name=\"start_time\" id=\"startTime\" value=\"2026-04-14 07:17:47\" \/>\n\t<input type=\"hidden\" name=\"start_timestamp\" id=\"startTimeStamp\" value=\"1776151067\" \/>\n\t<input type=\"hidden\" name=\"question_ids\" value=\"\" \/>\n\t<input type=\"hidden\" name=\"watupro_questions\" value=\"400367:1554891,1554892,1554893,1554894 | 400368:1554895,1554896,1554897,1554898 | 400369:1554899,1554900,1554901,1554902 | 400370:1554903,1554904,1554905,1554906 | 400371:1554907,1554908,1554909,1554910 | 400372:1554911,1554912,1554913,1554914 | 400373:1554915,1554916,1554917,1554918 | 400374:1554919,1554920,1554921,1554922 | 400375:1554923,1554924,1554925,1554926 | 400376:1554927,1554928,1554929,1554930 | 400377:1554931,1554932,1554933,1554934 | 400378:1554935,1554936,1554937,1554938 | 400379:1554939,1554940,1554941,1554942 | 400380:1554943,1554944,1554945,1554946 | 400381:1554947,1554948,1554949,1554950 | 400382:1554951,1554952,1554953,1554954 | 400383:1554955,1554956,1554957,1554958 | 400384:1554959,1554960,1554961,1554962 | 400385:1554963,1554964,1554965,1554966 | 400386:1554967,1554968,1554969,1554970 | 400387:1554971,1554972,1554973,1554974 | 400388:1554975,1554976,1554977,1554978 | 400389:1554979,1554980,1554981,1554982 | 400390:1554983,1554984,1554985,1554986 | 400391:1554987,1554988,1554989,1554990 | 400392:1554991,1554992,1554993,1554994 | 400393:1554995,1554996,1554997,1554998 | 400394:1554999,1555000,1555001,1555002 | 400395:1555003,1555004,1555005,1555006 | 400396:1555007,1555008,1555009,1555010 | 400397:1555011,1555012,1555013,1555014 | 400398:1555015,1555016,1555017,1555018 | 400399:1555019,1555020,1555021,1555022 | 400400:1555023,1555024,1555025,1555026 | 400401:1555027,1555028,1555029,1555030 | 400402:1555031,1555032,1555033,1555034 | 400403:1555035,1555036,1555037,1555038 | 400404:1555039,1555040,1555041,1555042 | 400405:1555043,1555044,1555045,1555046 | 400406:1555047,1555048,1555049,1555050 | 400407:1555051,1555052,1555053,1555054 | 400408:1555055,1555056,1555057,1555058 | 400409:1555059,1555060,1555061,1555062 | 400410:1555063,1555064,1555065,1555066 | 400411:1555067,1555068,1555069,1555070 | 400412:1555071,1555072,1555073,1555074 | 400413:1555075,1555076,1555077,1555078 | 400414:1555079,1555080,1555081,1555082 | 400415:1555083,1555084,1555085,1555086 | 400416:1555087,1555088,1555089,1555090\" \/>\n\t<input type=\"hidden\" name=\"no_ajax\" value=\"0\">\t\t\t<\/form>\n\t<p>&nbsp;<\/p>\n<\/div>\n\n<script type=\"text\/javascript\">\n\/\/jQuery(document).ready(function(){\ndocument.addEventListener(\"DOMContentLoaded\", function(event) { \t\nvar question_ids = \"400367,400368,400369,400370,400371,400372,400373,400374,400375,400376,400377,400378,400379,400380,400381,400382,400383,400384,400385,400386,400387,400388,400389,400390,400391,400392,400393,400394,400395,400396,400397,400398,400399,400400,400401,400402,400403,400404,400405,400406,400407,400408,400409,400410,400411,400412,400413,400414,400415,400416\";\nWatuPROSettings[10077] = {};\nWatuPRO.qArr = question_ids.split(',');\nWatuPRO.exam_id = 10077;\t    \nWatuPRO.post_id = 102412;\nWatuPRO.store_progress = 0;\nWatuPRO.curCatPage = 1;\nWatuPRO.requiredIDs=\"0\".split(\",\");\nWatuPRO.hAppID = \"0.03153700 1776151067\";\nvar url = \"https:\/\/www.dumpsbase.com\/freedumps\/wp-content\/plugins\/watupro\/show_exam.php\";\nWatuPRO.examMode = 1;\nWatuPRO.siteURL=\"https:\/\/www.dumpsbase.com\/freedumps\/wp-admin\/admin-ajax.php\";\nWatuPRO.emailIsNotRequired = 0;\nWatuPROIntel.init(10077);\nWatuPRO.inCategoryPages=1;});    \t \n<\/script>\n","protected":false},"excerpt":{"rendered":"<p>When visiting the ACRP-CP dumps of DumpsBase, you may know, \u201cDumpsBase offers the latest ACRP-CP exam dumps, expertly crafted to match the actual exam format and content. These practice questions will help you optimize your study time, build confidence, and increase your chances of passing the ACRP-Certified Professional (ACRP-CP) exam on your first attempt.\u201d If [&hellip;]<\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[18956,18957],"tags":[18960,18958,18959],"class_list":["post-102412","post","type-post","status-publish","format-standard","hentry","category-acrp","category-acrp-certified-professional","tag-acrp-certified-professional-exam","tag-acrp-cp","tag-acrp-cp-dumps"],"_links":{"self":[{"href":"https:\/\/www.dumpsbase.com\/freedumps\/wp-json\/wp\/v2\/posts\/102412","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.dumpsbase.com\/freedumps\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.dumpsbase.com\/freedumps\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.dumpsbase.com\/freedumps\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.dumpsbase.com\/freedumps\/wp-json\/wp\/v2\/comments?post=102412"}],"version-history":[{"count":1,"href":"https:\/\/www.dumpsbase.com\/freedumps\/wp-json\/wp\/v2\/posts\/102412\/revisions"}],"predecessor-version":[{"id":102413,"href":"https:\/\/www.dumpsbase.com\/freedumps\/wp-json\/wp\/v2\/posts\/102412\/revisions\/102413"}],"wp:attachment":[{"href":"https:\/\/www.dumpsbase.com\/freedumps\/wp-json\/wp\/v2\/media?parent=102412"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.dumpsbase.com\/freedumps\/wp-json\/wp\/v2\/categories?post=102412"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.dumpsbase.com\/freedumps\/wp-json\/wp\/v2\/tags?post=102412"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}